Movatterモバイル変換


[0]ホーム

URL:


US6609793B2 - Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations - Google Patents

Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
Download PDF

Info

Publication number
US6609793B2
US6609793B2US09/863,546US86354601AUS6609793B2US 6609793 B2US6609793 B2US 6609793B2US 86354601 AUS86354601 AUS 86354601AUS 6609793 B2US6609793 B2US 6609793B2
Authority
US
United States
Prior art keywords
lens
corneal
aberrations
wavefront
cornea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US09/863,546
Other versions
US20020105617A1 (en
Inventor
Sverker Norrby
Pablo Artal
Patricia Ann Piers
Marrie Van Der Mooren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AMO Groningen BV
Original Assignee
Pharmacia Groningen BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0001925Aexternal-prioritypatent/SE0001925D0/en
Priority claimed from SE0004830Aexternal-prioritypatent/SE0004830D0/en
Priority to US09/863,546priorityCriticalpatent/US6609793B2/en
Application filed by Pharmacia Groningen BVfiledCriticalPharmacia Groningen BV
Assigned to PHARMACIA ABreassignmentPHARMACIA ABASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).Assignors: ARTAL, PABLO, NORRBY, SVERKER, PIERS, PATRICIA ANN, VAN DER MOOREN, MARRIE
Publication of US20020105617A1publicationCriticalpatent/US20020105617A1/en
Assigned to PHARMACIA GRONINGEN BVreassignmentPHARMACIA GRONINGEN BVASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).Assignors: PHARMACIA AB
Priority to US10/606,910prioritypatent/US7241311B2/en
Application grantedgrantedCritical
Publication of US6609793B2publicationCriticalpatent/US6609793B2/en
Assigned to BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENTreassignmentBANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENTSECURITY AGREEMENTAssignors: ADVANCED MEDICAL OPTICS, INC.
Assigned to AMO GRONINGEN B.V.reassignmentAMO GRONINGEN B.V.CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).Assignors: PHARMACIA GRONINGEN B.V.
Priority to US11/619,098prioritypatent/US20070121064A1/en
Assigned to ADVANCED MEDICAL OPTICS, INC.reassignmentADVANCED MEDICAL OPTICS, INC.RELEASE OF SECURITY INTEREST AT REEL/FRAME NO. 14913/0655Assignors: BANK OF AMERICA, N.A.
Priority to US11/742,996prioritypatent/US20070258044A1/en
Priority to US12/175,395prioritypatent/US7841720B2/en
Priority to US12/954,347prioritypatent/US8020995B2/en
Priority to US13/222,944prioritypatent/US8556426B2/en
Priority to US14/053,034prioritypatent/US8998415B2/en
Priority to US14/668,596prioritypatent/US9504377B2/en
Priority to US15/356,423prioritypatent/US20170065165A1/en
Anticipated expirationlegal-statusCritical
Expired - Lifetimelegal-statusCriticalCurrent

Links

Images

Classifications

Definitions

Landscapes

Abstract

The present invention discloses methods of obtaining ophthalmic lens capable of reducing the aberrations of the eye comprising the steps of characterizing at least one corneal surface as a mathematical model, calculating the resulting aberrations of said corneal surface(s) by employing said mathematical model, selecting the optical power of the intraocular lens. From this information, an ophthalmic lens is modeled so a wavefront arriving from an optical system comprising said lens and corneal model obtains reduced aberrations in the eye. Also disclosed are ophthalmic lenses as obtained by the methods which are capable reducing aberrations of the eye.

Description

This application claims benefit of Provisional Applns. Nos. 60/207,734 and 60/259,924 filed on May 26, 2000 and Jan. 5, 2001, respectively.
FIELD OF INVENTION
The present invention relates to methods of designing ophthalmic lenses that provide the eye with reduced aberrations, as well as lenses capable of providing such visual improvements.
BACKGROUND OF THE INVENTION
It is presently discussed that the visual quality of eyes having an implanted intraocular lens (IOL) is comparable with normal eyes in a population of the same age. Consequently, a 70 year old cataract patient can only expect to obtain the visual quality of a non-cataracteous person of the same age after surgical implantation of an intraocular lens, although such lenses objectively has been regarded as optically superior than the natural crystalline lens. This result is likely to be explained by the fact that present IOLs are not adapted to compensate for defects of the optical system of the human eye. Age-related defects of the eye have recently been investigated and it is found that contrast sensitivity significantly declines in subjects older than 50 years. These results seem to comply with the above-mentioned discussion, since the contrast sensitivity measurements indicate that individuals having undergone cataract surgery with lens implantation lens will not obtain a better contrast sensitivity than persons of an average age of about 60 to 70 years.
Even if intraocular lenses aimed to substitute the defect cataract lens and other ophthalmic lenses, such as conventional contact lenses, have been developed with excellent optical quality, it is obvious that they fail to correct for a number of aberration phenomena of the eye including age-related aberration defects.
U.S. Pat. No. 5,777,719 (Williams et. al.) discloses a method and an apparatus for accurately measuring higher aberrations of the eye as an optical system with wavefront analysis. By using a Hartmann-Shack wavefront sensor, it is possible to measure higher order aberrations of the eye and using such data to find compensation for these aberrations and thereby obtain sufficient information for the production of an optical lens, which can provide a highly improved optical correction. The Hartmann-Shack sensor provides means for obtaining light reflected from the retina of the eye of a subject. The wavefront in the plane of the pupil is recreated in the plane of the lenslet array of the Hartmann-Shack sensor. Each lenslet in the array is used to form an aerial image of the retinal point source on a CCD camera located adjacent to the array. The wave these aberrations and thereby obtain sufficient information for the design of an optical lens, which can provide a highly improved optical performance. The Hartmann-Shack sensor provides means for analyzing light reflected from a point on the retina of the eye of a subject. The wavefront in the plane of the pupil is recreated in the plane of the lenslet array of the Hartmann-Shack sensor. Each lenslet in the array is used to form an aerial image of the retinal point source on a CCD camera located at the focal plane of the array. The wave aberration of the eye, in the form resulting from a point source produced on the retina by a laser beam, displaces each spot by an amount proportional to the local slope of the wavefront at each of the lenslets. The output from the CCD camera is sent to a computer, which then performs calculations to fit slope data to the first derivatives of 66 Zernike polynomials. From these calculations, coefficients for weighting the Zernike polynomials are obtained. The sum of the weighted Zernike polynomials represents a reconstructed wavefront distorted by the aberrations of the eye as an optical system. The individual Zernike polynomial terms will then represent different modes of aberration.
U.S. Pat. No. 5,050,981 (Roffman) discloses-another method for designing a lens by calculating modulation transfer functions from tracing a large number of rays through the lens-eye system and evaluating the distribution density of the rays in the image position. This is repeatedly performed by varying at least one lens surface until a lens is found which results in a sharp focus and a maximum modulation transfer function.
U.S. Pat. No. 6,224,211 (Gordon) describes a method of improving the visual acuity of the human eye by successively fitting aspheric lenses to the cornea and thereby finding a lens that can reduce spherical aberration of the whole individual eye.
The methods referred to above for designing are suitable for the design of contact lenses or other correction lenses for the phakic eye which can be perfected to compensate for the aberration of the whole eye system. However, to provide improved intraocular lenses aimed to replace the natural crystalline lens, it would be necessary to consider the aberrations of the individual parts of the eye.
U.S. Pat. No. 6,050,687 (Bille et al) refers to a method wherein the refractive properties of the eye are measured and wherein consideration is taken to the contribution of the individual surfaces of the eye to the total wavefront aberrations. The method described herein particularly aims at analyzing the topography of the posterior corneal surface in order to improve refractive correction techniques.
There has recently been a focus on studying the aberrations of the eye, including a number of studies of the development of these aberrations as a function of age. In two particular studies, the development of the components of the eye were examined separately, leading to the conclusion that the optical aberrations of the individual components of younger eyes cancel each other out, see Optical Letters, 1998, Vol. 23(21), pp. 1713-1715 and IOVS, 2000, Vol 41(4), 545. The article of S. Patel et al in Refractive & Corneal Surgery, 1993, Vol. 9, pages 173-181 discloses the asphericity of posterior corneal surfaces. It is suggested that the corneal data can be used together with other ocular parameters to predict the power and the asphericity of an intraocular lens with the purpose of maximizing the optical performances of the future pseudophakic eye. Furthermore, it was also recently observed by Antonio Guirao and Pablo Artal in IOVS, 1999, Vol. 40(4), S535 that the shape of the cornea in the subjects provides a positive spherical. These studies indicate that the cornea in the subjects provides a positive spherical aberration, which increases slightly with the age. On the other hand, the rotationally symmetric aberration of the anterior corneal surface does not seem to be different between younger and older eye according to results found by T Oshika et al in Investigative Ophthalmology and Visual Science, 1999,Vol 40, pp. 1351-1355. In Vision Research, 1998, 38(2), pp. 209-229, A Glasser et al. investigated the spherical aberration of natural crystalline lenses from eyes obtained from an eye bank after the cornea has been removed. According to the laser scanner optical method used herein it was found that the spherical aberration from an older lens (66 years) shows positive spherical aberration, whereas a 10-year-old lens shows negative spherical aberration. In addition, Vision Research, 2001, 41, pp.235-243 (G Smith et al) discloses that the natural crystalline lens appears to have negative spherical aberration when in the relaxed state. Smith et al suggest that because older eyes have a larger aberration, it is likely that the spherical aberration of the crystalline lens becomes less negative with age.
In Ophthal. Physiol. Opt., 1991, Vol. 11, pp. 137-143 (D A Atchison) it is discussed how to reduce spherical aberrations in intraocular lenses by aspherizing the lens surface. The methods outlined by Atchison are based on geometric transferring calculations, which do not consider diffraction effects and any variations in refractive index along the ray path in inhomogeneous elements. These calculations will lead to errors close to the diffraction limit. Also in WO 98/31299 (Technomed) a ray tracing method is outlined according to which the refraction of the cornea is attempted to be considered for the design of an intraocular lens. In view of the foregoing, it is apparent that there is a need for ophthalmic lenses that are better adapted or compensated to the aberrations of the individual surfaces of the eye and are capable of better correcting aberrations other than defocus and astigmatism, as provided by conventional ophthalmic lenses.
DESCRIPTION OF THE INVENTION
It is an object of the invention to provide for methods that result in obtaining an ophthalmic lens, which provides the eye with reduced aberrations.
It is another object of the invention to provide methods of obtaining an intraocular lens capable of reducing the aberration of the eye after its implantation into the eye.
It is a further object to provide for methods of obtaining an intraocular lens capable of compensating the aberrations resulting from optical irregularities in the corneal surfaces.
It is a still further object of the present invention to provide an intraocular lens which is capable of restoring a wavefront deviating from sphericity into a substantially more spherical wavefront.
It is also an object of the present invention to provide an intraocular lens which is capable of correcting for mean optical irregularities and imperfections found in a particular group of people and thereby provide a lens with improved optical performance for an individual belonging to the same group.
The present invention generally relates to an ophthalmic lens and to methods of obtaining said ophthalmic lens that is capable of reducing the aberrations of the eye. By aberrations in this context is meant wavefront aberrations. This is based on the understanding that a converging wavefront must be perfectly spherical to form a point image, i.e. if a perfect image shall be formed on the retina of the eye, the wavefront having passed the optical surfaces of the eye, such as the cornea and a natural or artificial lens, must be perfectly spherical. An aberrated image will be formed if the wavefront deviates from being spherical. In this context the term nonspherical surface will refer to rotationally symmetric, asymmetric and/or irregular surfaces, i.e. all surfaces differing from a sphere. The wavefront aberrations can be expressed in mathematical terms in accordance with different approximate models as is explained in textbook references, such as M. R. Freeman, Optics, Tenth Edition, 1990.
In a first embodiment, the present invention is directed to a method of designing an intraocular lens capable of reducing aberrations of the eye after its implantation. The method comprises a first step of characterizing at least one corneal surface as a mathematical model and by employing the mathematical model calculating the resulting aberrations of the corneal surface. An expression of the corneal aberrations is thereby obtained, i.e. the wavefront aberrations of a spherical wavefront having passed such a corneal surface. Dependent on the selected mathematical model different routes to calculate the corneal aberrations can be taken. Preferably, the corneal surface is characterized as a mathematical model in terms of a conoid of rotation or in terms of polynomials or a combination thereof. More preferably, the corneal surface is characterized in terms of a linear combination of polynomials. The second step of the method is to select the power of the intraocular lens, which is done according to conventional methods for the specific need of optical correction of the eye, for example the method described in U.S. Pat. No. 5,968,095. From the information of steps one and two an intraocular lens is modeled, such that a wavefront from an optical system comprising said lens and corneal model obtains reduced aberrations. The optical system considered when modeling the lens typically includes the cornea and said lens, but in the specific case it can also include other optical elements including the lenses of spectacles, or an artificial correction lens, such as a contact lens, a corneal inlay implant or an implantable correction lens depending on the individual situation.
Modeling the lens involves selection of one or several lens parameters in a system which contributes to determine the lens shape of a given, pre-selected refractive power. This typically involves the selection of the anterior radius and surface shape, posterior radius and surface shape, the lens thickness and the refractive index of the lens. In practical terms, the lens modeling can be performed with data based on a conventional spherical lens, such as the CeeOn® lenses from Pharmacia Corp., as exemplified with the CeeOn® Edge (Model 911). In such a case, it is preferred to deviate as little as possible from an already clinically approved model. For this reason, it may be preferred to maintain pre-determined values of the central radii of the lens, its thickness and refractive index, while selecting a different shape of the anterior and/or posterior surface, thus providing one or both of these surfaces to have an nonspherical shape. According to an alternative of the inventive method, the spherical anterior surface of the conventional starting lens is modeled by selecting a suitable aspheric component. Preferably the lens has at least one surface described as a nonsphere or other conoid of rotation. Designing nonspherical surfaces of lenses is a well-known technique and can be performed according to different principles and the description of such surfaces is explained in more detail in our parallel Swedish Patent Application 0000611-4 to which is given reference.
The inventive method can be further developed by comparing wavefront aberrations of an optical system comprising the lens and the model of the average cornea with the wavefront aberrations of the average cornea and evaluating if a sufficient reduction in wavefront aberrations is obtained. Suitable variable parameters are found among the above-mentioned physical parameters of the lens, which can be altered so as to find a lens model, which deviates sufficiently from being a spherical lens to compensate for the corneal aberrations.
The characterization of at least one corneal surface as a mathematical model and thereby establishing a corneal model expressing the corneal wavefront aberrations is preferably performed by direct corneal surface measurements according to well-known topographical measurement methods which serve to express the surface irregularities of the cornea in a quantifiable model that can be used with the inventive method. Corneal measurements for this purpose can be performed by the ORBSCAN® videokeratograph, as available from Orbtech, or by corneal topography methods, such as EyeSys® from Premier Laser Systems. Preferably, at least the front corneal surface is measured and more preferably both front and rear corneal surfaces are measured and characterized and expressed together in resulting wavefront aberration terms, such as a linear combination of polynomials which represent the total corneal wavefront aberrations. According to one import aspect of the present invention, characterization of corneas is conducted on a selected population with the purpose of expressing an average of corneal wavefront aberrations and designing a lens from such averaged aberrations. Average corneal wavefront aberration terms of the population can then be calculated, for example as an average linear combination of polynomials and used in the lens design method. This aspect includes selecting different relevant populations, for example in age groups, to generate suitable average corneal surfaces. Advantageously, lenses can thereby be provided which are adapted to an average cornea of a population relevant for an individual elected to undergo cataract surgery or refractive correction surgery including implantation of an IOL or corneal inlays. The patient will thereby obtain a lens that gives the eye substantially less aberrations when compared to a conventional spherical lens.
Preferably, the mentioned corneal measurements also include the measurement of the corneal refractive power. The power of the cornea and the axial eye length are typically considered for the selection of the lens power in the inventive design method.
Also preferably, the wavefront aberrations herein are expressed as a linear combination of polynomials and the optical system comprising the corneal model and modeled intraocular lens provides for a wavefront having obtained a substantial reduction in aberrations, as expressed by one or more such polynomial terms. In the art of optics, several types of polynomials are available to skilled persons for describing aberrations. Suitably, the polynomials are Seidel or Zernike polynomials. According to the present invention Zernike polynomials preferably are employed.
The technique of employing Zernike terms to describe wavefront aberrations originating from optical surfaces deviating from being perfectly spherical is a state of the art technique and can be employed for example with a Hartmann-Shack sensor as outlined in J. Opt. Soc. Am., 1994, Vol. 11(7), pp. 1949-57. It is also well established among optical practitioners that the different Zernike terms signify different aberration phenomena including defocus, astigmatism, coma and spherical aberration up to higher aberrations. In an embodiment of the present method, the corneal surface measurement results in that a corneal surface is expressed as a linear combination of the first 15 Zernike polynomials. Be means of a ray tracing method, the Zernike description can be transformed to a resulting wavefront (as described in Equation (1)), wherein Z1is the i-th Zernike term and aiis the weighting coefficient for this term. Zernike polynomials are a set of complete orthogonal polynomials defined on a unit circle. Below, Table 1 shows the first 15 Zernike terms and the aberrations each term signifies.z(ρ,θ)=i115αiZi(1)
Figure US06609793-20030826-M00001
In equation (1), ρ and θ represent the normalized radius and the azimuth angle, respectively.
TABLE 1
iZi(ρ, θ)
11Piston
22ρcos θTilt x
32ρsinθTilt y
4{square root over (3)} (2ρ2− 1)Defocus
5{square root over (6)} (ρ2sin2θ)Astigmatism 1storder (45°)
6{square root over (6)} (ρ2cos2θ)Astigmatism 1storder (0°)
7{square root over (8)} (3ρ3− 2ρ)sinθComa y
8{square root over (8)} (3ρ3− 2ρ)cosθComa x
9{square root over (8)} (ρ3sin3θ)Trifoil 30°
10{square root over (8)} (ρ3cos3θ)Trifoil
11{square root over (5)} (6ρ4− 6ρ2+ 1)Spherical aberration
12{square root over (10)} (4ρ4− 3ρ2)cos 2θAstigmatism 2ndorder (0°)
13{square root over (10)} (4ρ4− 3ρ2)sin 2θAstigmatism 2ndorder (45°)
14{square root over (10)} (4ρ4cos4θ)Tetrafoil 0°
15{square root over (10)} (ρ4sin4θ)Tetrafoil 22.5°
Conventional optical correction with intraocular lenses will only comply with the fourth term of an optical system comprising the eye with an implanted lens. Glasses, contact lenses and some special intra ocular lenses provided with correction for astigmatism can further comply with terms five and six and substantially reducing Zernike polynomials referring to astigmatism.
The inventive method further includes to calculate the wavefront aberrations resulting from an optical system comprising said modeled intraocular lens and cornea and expressing it in a linear combination of polynomials and to determine if the intraocular lens has provided sufficient reduction in wavefront aberrations. If the reduction in wavefront aberrations is found to be insufficient, the lens will be re-modeled until one or several of the polynomial terms are sufficiently reduced. Remodeling the lens means that at least one lens design parameter is changed. These include the anterior surface shape and central radius, the posterior surface shape and central radius, the thickness of the lens and its refractive index. Typically, such remodeling includes changing the shape of a lens surface so it deviates from being a spherical. There are several tools available in lens design that are useful to employ with the design method, such asOSLO version 5 see Program Reference,Chapter 4, Sinclair Optics 1996. The format of the Zernike polynomials associated with this application are listed in Table 1.
According to a preferred aspect of the first embodiment, the inventive method comprises expressing at least one corneal surface as a linear combination of Zernike polynomials and thereby determining the resulting corneal wavefront Zernike coefficients, i.e. the coefficient of each of the individual Zernike polynomials that is selected for consideration. The lens is then modeled so that an optical system comprising of said model lens and cornea provides a wavefront having a sufficient reduction of selected Zernike coefficients. The method can optionally be refined with the further steps of calculating the Zernike coefficients of the Zernike polynomials representing a wavefront resulting from an optical system comprising the modeled intraocular lens and cornea and determining if the lens has provided a sufficient reduction of the wavefront Zernike coefficients of the optical system of cornea and lens; and optionally re-modeling said lens until a sufficient reduction in said coefficients is obtained. Preferably, in this aspect the method considers Zernike polynomials up to the 4th order and aims to sufficiently reduce Zernike coefficients referring to spherical aberration and/or astigmatism terms. It is particularly preferable to sufficiently reduce the 11th Zernike coefficient of a wavefront front from an optical system comprising cornea and said modeled intraocular lens, so as to obtain an eye sufficiently free from spherical aberration. Alternatively, the design method can also include reducing higher order aberrations and thereby aiming to reduce Zernike coefficients of higher order aberration terms than the 4thorder.
When designing lenses based on corneal characteristics from a selected population, preferably the corneal surfaces of each individual are expressed in Zernike polynomials describing the surface topography and therefrom the Zernike coefficients of the wavefront aberration are determined. From these results average Zernike wavefront aberration coefficients are calculated and employed in the design method, aiming at a sufficient reduction of selected such coefficients. In an alternative method according to the invention, average values of the Zernike polynomials describing the surface topography are instead calculated and employed in the design method. It is to be understood that the resulting lenses arriving from a design method based on average values from a large population have the purpose of substantially improving visual quality for all users. A lens having a total elimination of a wavefront aberration term based on an average value may consequently be less desirable and leave certain individuals with an inferior vision than with a conventional lens. For this reason, it can be suitable to reduce the selected Zernike coefficients only to certain degree of the average value.
According to another approach of the inventive design method, corneal characteristics of a selected population and the resulting linear combination of polynomials, e.g. Zernike polynomials, expressing each individual corneal aberration can be compared in terms of coefficient values. From this result, a suitable value of the coefficients is selected and employed in the inventive design method for a suitable lens. In a selected population having aberrations of the same sign such a coefficient value can typically be the lowest value within the selected population and the lens designed from this value would thereby provide improved visual quality for all individuals in the group compared to a conventional lens. One embodiment of the method comprises selecting a representative group of patients and collecting corneal topographic data for each subject in the group. The method comprises further transferring said data to terms representing the corneal surface shape of each subject for a preset aperture size representing the pupil diameter. Thereafter a mean value of at least one corneal surface shape term of said group is calculated, so as to obtain at least one mean corneal surface shape term. Alternatively or complementary a mean value of at least one to the cornea corresponding corneal wavefront aberration term can be calculated. The corneal wavefront aberration terms are obtained by transforming corresponding corneal surface shape terms using a raytrace procedure. From said at least one mean corneal surface shape term or from said at least one mean corneal wavefront aberration term an ophthalmic lens capable of reducing said at least one mean wavefront aberration term of the optical system comprising cornea and lens is designed.
In one preferred embodiment of the invention the method further comprises designing an average corneal model for the group of people from the calculated at least one mean corneal surface shape term or from the at least one mean corneal wavefront aberration term. It also comprises checking that the designed ophthalmic lens compensates correctly for the at least one mean aberration term. This is done by measuring these specific aberration terms of a wavefront having traveled through the model average cornea and the lens. The lens is redesigned if said at least one aberration term has not been sufficiently reduced in the measured wavefront.
Preferably one or more surface descriptive (asphericity describing) constants are calculated for the lens to be designed from the mean corneal surface shape term or from the mean corneal wavefront aberration terms for a predetermined radius. The spherical radius is determined by the refractive power of the lens.
The corneal surfaces are preferably characterized as mathematical models and the resulting aberrations of the corneal surfaces are calculated by employing the mathematical models and raytracing techniques. An expression of the corneal wavefront aberrations is thereby obtained, i.e. the wavefront aberrations of a wavefront having passed such a corneal surface. Dependent on the selected mathematical model different routes to calculate the corneal wavefront aberrations can be taken. Preferably, the corneal surfaces are characterized as mathematical models in terms of a conoid of rotation or in terms of polynomials or a combination thereof. More preferably, the corneal surfaces are characterized in terms of linear combinations of polynomials.
In one embodiment of the invention, the at least one nonspheric surface of the lens is designed such that the lens, in the context of the eye, provides to a passing wavefront at least one wavefront aberration term having substantially the same value but with opposite sign to a mean value of the same aberration term obtained from corneal measurements of a selected group of people, to which said patient is categorized. Hereby a wavefront arriving from the cornea of the patient's eye obtains a reduction in said at least one aberration term provided by the cornea after passing said lens. The used expression ‘in the context of the eye’ can mean both in the real eye and in a model of an eye. In a specific embodiment of the invention, the wavefront obtains reduced aberration terms expressed in rotationally symmetric Zernike terms up to the fourth order. For this purpose, the surface of the ophthalmic lens is designed to reduce a positive spherical aberration term of a passing wavefront. The consequence of this is that if the cornea is a perfect lens and thus not will give rise to any wavefront aberration terms the ophthalmic lens will provide the optical system comprising the cornea and the ophthalmic lens with a negative wavefront spherical aberration term. In this text positive spherical aberration is defined such that a spherical surface with positive power produces positive spherical aberration. Preferably the lens is adapted to compensate for spherical aberration and more preferably it is adapted to compensate for at least one term of a Zernike polynomial representing the aberration of a wavefront, preferably at least the 11thZernike term, see Table 1.
The selected groups of people could for example be a group of people belonging to a specific age interval, a group of people who will undergo a cataract surgical operation or a group of people who have undergone corneal surgery including but not limited to LASIK (laser in situ keratomileusis), RK (radial keratotomy) or PRK (photorefractive keratotomy). The group could also be a group of people who have a specific ocular disease or people who have a specific ocular optical defect.
The lens is also suitably provided with an optical power. This is done according to conventional methods for the specific need of optical correction of the eye. Preferably the refractive power of the lens is less than or equal to 30 diopters. An optical system considered when modeling the lens to compensate for aberrations typically includes the average cornea and said lens, but in the specific case it can also include other optical elements including the lenses of spectacles, or an artificial correction lens, such as a contact lens, a corneal inlay or an implantable correction lens depending on the individual situation.
In an especially preferred embodiment the ophthalmic lens is designed for people who will undergo a cataract surgery. In this case it is has been shown that the average cornea from such a population is represented by a prolate surface following the formula:z=(1R)r21+1-(1R)2(cc+1)r2+adr4+aer6
Figure US06609793-20030826-M00002
wherein,
(i) the conical constant cc has a value ranging between −1 and 0
(ii) R is the central lens radius and
(iii) ad and ae are aspheric polynomial coefficients additional to the conical constant.
In these studies the conic constant of the prolate surface ranges between about −0.05 for an aperture size (pupillary diameter) of 4 mm to about −0.18 for an aperture size of 7 mm. Accordingly an ophthalmic lens suitable to improve visual quality by reducing at least spherical aberration for a cataract patient based on an average corneal value will have a prolate surface following the formula above. Since cornea generally produces a positive spherical aberration to a wavefront in the eye, an ophthalmic lens for implantation into the eye will have negative spherical aberration terms while following the mentioned prolate curve. As will discussed in more detail in the exemplifying part of the specification, it has been found that an intraocular lens that can correct for 100% of a mean spherical aberration has a conical constant (cc) with a value of less than 0 (representing a modified conoid surface), with an exact value dependent on the design pupillary diameter and the selected refractive power. For example, a 6 mm diameter aperture will provide a 22 diopter lens with conical constant value of about −1.03. In this embodiment, the ophthalmic lens is designed to balance the spherical aberration of a cornea that has a Zernike polynomial coefficient representing spherical aberration of the wavefront aberration with a value in the interval from 0.000156 mm to 0.001948 mm for a 3 mm aperture radius, 0.000036 mm to 0.000448 mm for a 2 mm aperture radius, 0.0001039 mm to 0.0009359 mm for a 2,5 mm aperture radius and 0.000194 mm to 0.00365 mm for a 3,5 mm aperture radius using polynomials expressed in OSLO format. These values were calculated for a model cornea having a single surface with a refractive index of the cornea of 1.3375. It is possible to use optically equivalent model formats of the cornea without departing from the scope of the invention. For example multiple surface corneas or corneas with different refractive indices could be used. The lower values in the intervals are here equal to the measured average value for that specific aperture radius minus one standard deviation. The higher values are equal to the measured average value for each specific aperture radius plus three standard deviations. The used average values and standard deviations are shown in tables 8, 9, 10 and 11. The reason for selecting only minus one SD(=Standard Deviation) while selecting plus three SD is that in this embodiment it is convenient to only compensate for positive corneal spherical aberration and more than minus one SD added to the average value would give a negative corneal spherical aberration.
According to one embodiment of the invention the method further comprises the steps of measuring the at least one wavefront aberration term of one specific patient's cornea and determining if the selected group corresponding to this patient is representative for this specific patient if this is the case the selected lens is implanted and if this is not the case a lens from another group is implanted or an individual lens for this patient is designed using this patients corneal description as a design cornea. These method steps are preferred since then patients with extreme aberration values of their cornea can be given special treatments.
According to another embodiment, the present invention is directed to the selection of an intraocular lens of refractive power, suitable for the desired optical correction that the patient needs, from a plurality of lenses having the same power but different aberrations. The selection method is similarly conducted to what has been described with the design method and involves the characterizing of at least one corneal surface with a mathematical model by means of which the aberrations of the corneal surface is calculated. The optical system of the selected lens and the corneal model is then evaluated so as to consider if sufficient reduction in aberrations is accomplished by calculating the aberrations of a wavefront arriving from such a system. If an insufficient correction is found a new lens is selected, having the same power, but different aberrations. The mathematical models employed herein are similar to those described above and the same characterization methods of the corneal surfaces can be employed.
Preferably, the aberrations determined in the selection are expressed as linear combinations of Zernike polynomials and the Zernike coefficients of the resulting optical system comprising the model cornea and the selected lens are calculated. From the coefficient values of the system, it can be determined if the intraocular lens has sufficiently balanced the corneal aberration terms, as described by the Zernike coefficients of the optical system. If no sufficient reduction of the desired individual coefficients are found these steps can be iteratively repeated by selecting a new lens of the same power but with different aberrations, until a lens capable of sufficiently reducing the aberrations of the optical system is found. Preferably at least 15 Zernike polynomials up to the 4thorder are determined. If it is regarded as sufficient to correct for spherical aberration, only the spherical aberration terms of the Zernike polynomials for the optical system of cornea and intraocular lens are corrected. It is to be understood that the intraocular lens shall be selected so a selection of these terms become sufficiently small for the optical system comprising lens and cornea. In accordance with the present invention, the 11thZernike coefficient, a11can be substantially eliminated or brought sufficiently close to zero. This is a prerequisite to obtain an intraocular lens that sufficiently reduces the spherical aberration of the eye. The inventive method can be employed to correct for other types of aberrations than spherical aberration by considering other Zernike coefficients in an identical manner, for example those signifying astigmatism, coma and higher order aberrations. Also higher order aberrations can be corrected dependent on the number of Zernike polynomials elected to be a part of the modeling, in which case a lens can be selected capable of correcting for higher order aberrations than the 4thorder.
According to one important aspect, the selection method involves selecting lenses from a kit of lenses having lenses with a range of power and a plurality of lenses within each power having different aberrations, in one example the lenses within each power have anterior surfaces with different aspherical components. If a first lens does not exhibit sufficient reduction in aberration, as expressed in suitable Zernike coefficients, then a new lens of the same power, but with a different surface (aspheric component) is selected. The selection method can if necessary be iteratively repeated until the best lens is found or the studied aberration terms are reduced below a significant borderline value. In practice, the Zernike terms obtained from the corneal examination will be directly obtained by the ophthalmic surgeon and by means of an algorithm they will be compared to known Zernike terms of the lenses in the kit. From this comparison the most suitable lens in the kit can be found and implanted. Alternatively, the method can be conducted before cataract surgery and data from the corneal estimation is sent to a lens manufacturer for production of an individually tailored lens.
The present invention further pertains to an intraocular lens having at least one nonspherical surface capable of transferring a wavefront having passed through the cornea of the eye into a substantially spherical wavefront with its center at the retina of the eye. Preferably, the wavefront is substantially spherical with respect to aberration terms expressed in rotationally symmetric Zernike terms up to the fourth order.
In accordance with an especially preferred embodiment, the invention relates to an intraocular lens, which has at least one surface, when expressed as a linear combination of Zernike polynomial terms using the normalized format, that has a negative 11thterm of the fourth order with a Zernike coefficient a11that can balance a positive such term of the cornea to obtain sufficient reduction of the spherical aberration of the eye after implantation. In one aspect of this embodiment, the Zernike coefficient a11of the lens is determined so as to compensate for an average value resulting from a sufficient number of estimations of the Zernike coefficient a11in several corneas. In another aspect, the Zernike coefficient a11is determined to compensate for the individual corneal coefficient of one patient. The lens can accordingly be tailored for an individual with high precision.
The invention further relates to another method of providing a patient with an intraocular lens, which at least party compensates for the aberrations of the eye. This method comprises removing the natural lens from the eye. Surgically removing the impaired lens can be performed by using a conventional phacoemulsification method. The method further comprises measuring the aberrations of the aphakic eye, not comprising a lens, by using a wavefront sensor. Suitable methods for wavefront measurements are found in J. Opt. Soc. Am., 1994, Vol 11(7), pp. 1949-57 by Liang et. al. Furthermore, the method comprises selecting from a kit of lenses a lens that at least partly compensates for the measured aberrations and implanting said lens into the eye. The kit of lenses comprises lenses of different power and different aberrations and finding the most suitable lens can be performed in a manner as earlier discussed. Alternatively, an individually designed lens for the patient can be designed based on the wavefront analysis of the aphakic eye for subsequent implantation. This method is advantageous, since no topographical measurements of the cornea are and the whole cornea, including the front and back surfaces, is automatically considered.
The lenses according to the present invention can be manufactured with conventional methods. In one embodiment they are made from soft, resilient material, such as silicones or hydrogels. Examples of such materials suitable for foldable intraocular lenses are found in U.S. Pat. No. 5,444,106 or in U.S. Pat. No. 5,236,970. Manufacturing of nonspherical silicone lenses or other foldable lenses can be performed according to U.S. Pat. No. 6,007,747. Alternatively, the lenses according to the present invention can be made of a more rigid material, such as poly(methyl)methacrylate. The skilled person can readily identify alternative materials and manufacturing methods, which will be suitable to employ to produce the inventive aberration reducing lenses.
DETAILED DESCRIPTION OF THE INVENTION
FIG. 1 shows a comparison of the a11(“Z11”) Zernike coefficient values for 10 subjects if implanted withCeeOn® 911 lenses and the inventive averaged (“Z11”) lens.
FIG. 2 shows modeled visual acuities of the test subjects withCeeOn® 911 lenses and the inventive averaged (“Z11”) lenses.
FIG.3 and FIG. 4 show modulation transfer function comparisons betweenCeeOn® 911 lenses and the inventive averaged (“Z11”) lenses
FIG. 5 shows visual acuity plotted as a function of the astigmatism of the lenses according to the model lenses according to the invention.
FIG. 6 shows the best corrected visual acuity with the inventive lenses.
FIGS. 7 and 8 show modulation transfer functions of an individual with an individually designed lens.
FIG. 9 shows the best corrected visual acuity with individually designed lenses according to the invention.
FIG. 10 shows the age distribution of 71 patients used in a study described below in the example part.
FIG. 11 shows a height map given by an Orbscan® true height data file.
FIG. 12 shows average corneal wavefront aberration coefficients.
FIG. 13 shows a scatter plot of the spherical aberration of 71 subjects for a 6 mm diameter aperture.
FIG. 14 shows a scatter plot of the spherical aberration of 71 subjects for a 4 mm diameter aperture.
FIG. 15 shows a scatter plot of the spherical aberration of 71 subjects for a 5 mm diameter aperture.
FIG. 16 shows a scatter plot of the spherical aberration of 71 subjects for a 7 mm diameter aperture.
EXAMPLE 1
A sample set of 10 corneal surfaces from individuals were described using Zernike polynomials. The sag data of the corneas was determined using the real height data measured with a Humphrey Atlas corneal topographer. The corneal topographer measures the height (zi) at a discrete number of points. The corneal surface can then be expressed as a linear combination of the first 15 Zernike polynomials (as described inEquation 1, above), where Ziis the ith Zernike polynomial and aiis the weighting coefficient for this polynomial. The Zernike polynomials are a set of complete orthogonal polynomials defined on a unit circle. These polynomials as listed in Table 1 above and the weighting coefficients (ai) are calculated from the height data using a Grahm-Schmidt orthogonalization procedure. The Zernike coefficients (ai) for the 10 sample corneas are listed in Table 2 in mm.
TABLE 2
The Zernike coefficients for the 10 individual corneal surfaces in mm.
ACHASACGRCNRFCAFCMFCZFGPJAEJBH
a1−7.713337−6.698643−7.222353−7.169027−7.001356−7.322624−7.03713−7.84427−7.582005−6.890056
a20.000271−0.0009850.000386−0.0005190.000426−0.000094−0.000236−0.00056−0.000344−0.000155
a30.000478−0.000002−0.0008470.000996−0.0003930.0000450.0004540.0003470.000246−0.000558
a40.0733090.0838780.0779610.0781460.0801110.0777890.0799870.0725950.0758030.081415
a5−0.000316−0.0007530.0001190.000347−0.0011970.00022−0.0000710.000686−0.000388−0.000269
a60.0016610.000411−0.000148−0.0003860.0003140.0006690.00079−0.000480.0016880.001492
a70.0001930.00006−0.0002950.000324−0.000161−0.0000580.0001480.000140.000104−0.000227
a80.000098−0.0004370.000146−0.000180.0001470.000039−0.000076−0.00025−0.000173−0.000116
a9−0.000091−0.000168−0.0001070.000047−0.000181−0.000154−0.0000430.000092−0.000023−0.000109
a10−0.0000550.000139−0.000132−0.0001490.000234−0.0002280.000244−8.2E-05−0.000004−0.000065
a110.0002770.0003940.0002030.0003050.0002850.0003150.0002130.0003080.0003090.0004
a12−0.000019−0.0001050.0000250.00007−0.000058−0.0000330.00009    −2E-06−0.000115−0.00011
a130.0000480.0000320.0000850.0000170.0000390.0000590.0000220.000101−0.000042−0.000052
a14−0.0000670.000041−0.000081−0.0000490.000118−0.0001080.000127−1.9E-05−0.0000680.00001
a15−0.000048−0.000075−0.000073−0.000019−0.000036−0.000119−0.0000210.000022−0.000013−0.000048
These wavefront aberration coefficients can be calculated using optical design software such as OSLO (Sinclair Optics). Table 3 shows the results of calculating the wavefront aberration for subject FOM. (N.B. The normalization factor for the polynomials used in OSLO is different from those shown in Table 3. This difference has been incorporated into the coefficient values.)
TABLE 3
The corneal aberration coefficients in mm calculated for subject FCM
using OSLO(N.B. OSLO numbering order)
Aberration Coefficients for FCM (OSLO)
A0 −0.000123
A1 4.5960e−07
A2 2.0869e−07
A3 −5.355e−06
A4 0.000551
A5 0.000182
A6 3.7296e−05
A7 −5.5286e−05
A8 0.000116
A9 −0.000217
A10−0.000147
A11−3.8151e−05
A126.1808e−05
A13−3.3056e−07
A144.888e−07
A15−1.8642e−06
A16−0.000115
A17−0.000127
EXAMPLE 2
An averaged design embodiment of the inventive lenses has been calculated using the average “old” cornea information provided by Pablo Artal, Murcia, Spain. This data was taken from a population sample of 16 old corneas in which all of the subjects had a visual acuity of 20/30 or better. The corneal surfaces were described using Zernike polynomials for an aperture of 2.0 nm radius (ro). The polynomial coefficients were then used to determine the radius and asphericityvalues using Equations 2 and 3.R=ro22(23a4-65a11)(2)
Figure US06609793-20030826-M00003
K2=8R3ro465a11(3)
Figure US06609793-20030826-M00004
Note that the asphericity constant, K, describes the surface's variation from a sphere (K2=1−e2) (i.e. For a sphere K=1 and for a parabola K=0). (cc=K2−1, wherein cc is the conical constant)
Because the cornea surface has only been described for a central diameter of 4 mm, the calculated R and K are also only accurate over the central 4 mm. A pupil size of 4.0 mm is therefore selected for design purposes. This pupil size is reasonable for intraocular lens design purposes.
A22D CeeOn® 911 lens from Pharmacia Corp was chosen as a starting point for the averaged lens design. For the purpose of comparison, the averaged lenses were also designed to be 22D. (Note that other diopters would give similar simulation results, provided that the spherical surfaces of the lenses is the same.) The surface information for the starting point eye model is summarized in Table 4. In the conical and aspherical data demonstrated in Table 4, the average conic constant CC is determined for the 10 individual corneas of Example 1.
TABLE 4
Surface data for the starting point of the averaged (“Z11”) design
SurfaceRadiusThicknessApertureConicRefractive
#(mm)(mm)Radius (mm)ConstantIndex
Object   2.2726111.0  
1 7.5733.6   2.272611−0.0784 *1.3375
(cornea)
22.01.3375
(pupil)
30.92.01.3375
4 (lens11.043 1.143.01.4577
1)
5 (lens−11.043  17.20973.01.336 
2)
* This conic constant for the “average” cornea is taken from the published works of Guirao and Artal
The wavefront aberration coefficients in mm for the average cornea are shown incolumn 1 of Table 5, while the coefficients in mm of the combination of the average cornea and the 911 lens are shown incolumn 2 of Table 5. Note that the Z11 coefficient (a11) of the average old cornea alone is 0.000220 mm, while the Z11 of this eye implanted with a 911 would be 0.000345 mm.
TABLE 5
Zernike coefficients in mm of the average cornea and the starting point
for design (Average cornea +911)
Average CorneaAverage Cornea +911
a1 0.0004320.000670
a2 0.00.0
a3 0.00.0
a4 0.0006500.0010
a5 0.00.0
a6 0.00.0
a7 0.00.0
a8 0.00.0
a9 0.00.0
a100.00.0
a110.0002200.000345
a120.00.0
a130.00.0
a140.00.0
a150.00.0
The averaged lens was optimized to minimize spherical aberration, while maintaining a 22D focal power. The lens material remained the same as in the22D 911 lens (HRI silicone, the refractive index of which is 1.45 in 77 at 37° C. The resulting design for an equiconvex lens is The averaged lens was optimized to minimize spherical aberration, while maintaining a 22D focal power. The lens material remained the same as in the22D 911 lens (HRI silicone, the refractive The resulting design for an equiconvex lens is provided in Table 6. The total-eye Z11 coefficient of the average cornea combined with this lens is −2.42×10−7mm (versus 0.000345 mm for the cornea plus 911 lens).
TABLE 6
Surface data for the starting point of the averagedlens design
4thOrder6thOrder
RadiusThicknessApertureConicAsphericAsphericRefractive
Surface #(mm)(mm)Radius (mm)ConstantConstantConstantIndex
Object   2.2726111.0  
1 (cornea)  7.5733.6   2.272611 −0.07841.3375
2 (pupil)2.01.3375
30.92.01.3375
4 (lens 1)10.0 1.023.0−2.809−0.000762−1.805e-051.4577
5 (lens 2)−12.0  17.20973.01.336 
The corneas of the 10 test subjects were combined in an optical system with both the 911 and the averaged lenses. The resulting total-eye Z11 coefficients are shown in FIG.1. As demonstrated, in FIG. 1, in each case, the absolute value of the Z11 coefficient was less when the Z11 lens was implanted. Because subjects CGR and FCZ have relatively low levels of corneal spherical aberration to begin with, the total-eye spherical aberration is overcorrected in these two cases. As a result, the sign of the total spherical aberration is noticeably reversed in these two cases, and the amount of spherical aberration is still significant. In every other case, the spherical aberration of the total eye would be essentially 0 after the implantation of a Z11 lens. The visual acuity of each of the 10 test subjects were calculated according to standard methods described in “Visual acuity modeling using optical raytracing of schematic eyes”, Greivenkamp et al., American journal of ophthalmology, 120(2), 227-240, (1995), for the implantation of both a22D 911 lens and a 22D avenged “Z11” lens. The square wave responses were calculated using OSLO™ and a software module was written in Matlab™ to calculate the visual acuity following the above method. The resulting visual acuities are shown in FIG.2. Out of the 10 cases investigated and shown in FIG. 2, eight subjects had better vision when implanted with the averaged lens according to the present invention. In the cases where the visual acuity decreased their Snellen distance increased by less than 1 ft which would not show up in visual acuity testing.
To be able to assess the optical quality difference between a CeeOn® 911A and averaged lenses according to the present invention, a physical model of the average cornea was designed and manufactured. It is a convex-plano lens of PMMA with an aspheric front surface having a value of 0.000218 for Zernike coefficient a11. This value is almost equal to the value of the calculated average cornea: 0.000220. With the PMMA model cornea MTF measurements were performed on an optical bench in a model eye with the “averaged” Z11 lenses and CeeOn®911A lenses. Modulation Transfer Function (MTF) measurements are a widely accepted method of quantifying image quality. Through focus MTF measurements at 50 c/mm and a frequency MTF curves focused at 50 c/mm, in both cases with a 3 mm pupil are shown in the FIG.3 and FIG. 4, respectively for lenses with an optical power of 20 D. The width of the through focus MTF at 0.2 MTF units is a measure for the depth of focus and is equal for both lenses. The MTF curve focussed at 50 c/mm for “averaged” Z11 lenses is almost diffraction limited and is better than that for CeeOn 911A lenses.
The astigmatism of the cornea and the defocus of the system can be corrected by adjusting the Zernike coefficients of the cornea model and the focal position of the system. When this is done and the procedure for calculating visual acuity is repeated the results in FIG. 6 are obtained. They represent a modeled best corrected visual acuity. We now see that, in all cases, after correction for astigmatism and defocus (as in reality would be done with spectacles) the inventive averaged lens produces a higher best corrected visual acuity than the 911 lens of the same dioptre.
EXAMPLE 3
Individually Designed Lenses
As a potential further improvement upon the averaged lens (“Z11 lenses”), an individualized lens (“I11 lenses”) was designed for each of four subject corneas employing the same design principles as demonstrated in Example 2. The individual lenses were designed such that the Z11 of the lens balances the Z11 of the individual cornea. The total-eye Z11 coefficients for the I11 lenses are shown in Table 7, together
TABLE 7
The Z11 coefficients in mm of the model eyes with the 911, Z11 and
I11 lenses
Subject911averagedindividual
CGR0.000107−0.000101−0.000004
FCZ0.000105−0.000100−0.000005
JAE0.000195−0.000016−0.000012
JBH0.000238  0.000037−0.000019
with the corresponding coefficients for the 911 and the averaged lenses. Furthermore, for each of the 911, Z11 (averaged), and I11 (individual) lenses, the MTF curve at best focussed at 50 c/mm and the through focus MTF at 50 c/mm for subject JAE are plotted below in FIGS. 7 and 8. From FIGS. 7 and 8, it is seen that the MTF at 50 c/mm of eyes implanted with the Z11 and I11 lenses is higher than the MTF of the same eyes implanted with 911 lenses. It can also be seen that the through focus MTF of all of the lenses is satisfactory. The Z11 has as much depth of focus as the 911. However, it is also interesting to note that the I11 does not provide a significant improvement in either MTF or through focus MTF, relative to the Z11 lens. The visual acuities of the subjects with individualized lenses have also been calculated. FIG. 9 compares these acuities with the visual acuity calculated for the 911 and Z11 lenses. From FIG. 9, we see that for all 4 subjects, visual acuity is better for both the Z11 and I11 lenses than it is for the 911 lens. We also see that the results with the Z11 and I11 lenses do not differ significantly—the average cornea is relatively accurate for each of the 4 test subjects.
EXAMPLE 4
The design of an ophthalmic lens, which is adapted to reduce the spherical aberration of an average cornea obtained from a group of people will be described in detail here below. The lens will be called the Z11 lens because it compensates for the normalized 11thZernike term describing spherical aberration of the corneas. It was decided to use a population of potential recipients of the Z11 lens, namely cataract patients.
Description of the Population
The population included 71 cataract patients from St. Erik's eye hospital in Stockholm, Sweden. These patients were of ages ranging from 35 to 94 years (as of Apr. 12, 2000). The average age of our population was 73.67 years. A histogram of the age of the population is shown in FIG.10.
The corneas of the 71 subjects were measured using an Orbscan® (Orbtek, Salt Lake City) device. Orbscan® is a scanning slit-based, corneal and anterior segment topographer that measures both surfaces of the cornea, as well as the anterior lens surface and the iris. Each surface can be displayed as maps of elevation, inclination, curvature, and power.
Fitting Algorithm
The corneal elevation height data (the Cartesian locations of points on the surface of the cornea) for the anterior surface was obtained using the Orbscan®, and used as raw data for the determination of the optical properties of the cornea. The height data from an example Orbscan® file is represented in FIG. 11
The Cartesian co-ordinates representing the elevation height data are transformed to polar co-ordinates (x,y,z→r,θ,z). In order to describe the surface, this data is then fit to a series of polynomials as described in Equation 1b. The coefficients (a's), or weighting factors, for each polynomial are determined by the fitting procedure resulting in a complete description of the surface. The polynomials (Zi) used are the normalized Zernike polynomials.z(ρ,θ)=i=1LaiZi(1b)
Figure US06609793-20030826-M00005
These polynomials are special because they are orthonormal over a continuous unit circle. They are commonly used to describe wavefront aberrations in the field of optics. Corneal topographers measure the elevation heights at a discrete number of points. The Zernike polynomials are not orthogonal over a discrete set of points. However, applying an orthogonalization procedure, termed Gram-Schmidt orthogonalization, to the height data, allows the data to be fit in terms of Zernike polynomials maintaining the advantages of an orthogonal fit. Sixty-six coefficients (a's) were used to fit the height data provided by the Orbscan® software. A Matlab™ algorithm was used in the fitting procedure. The radius and asphericity value can be approximated from the Zernike coefficients (Equations 2b and 3b) and the conic constant of the surface is simply K2−1 (from this we know that for a sphere K2=1). The fitting procedure is well described in a number of references. Four different articles are refereed to here: “Wavefront fitting with discrete orthogonal polynomials in a unit radius circle”, Daniel Malacara, Optical Engineering, June 1990, Vol. 29 No. 6, “Representation of videokeratoscopic height data with Zernicke polynomials”, J. Schwiegerling, J. Greivenkamp and J. Miller. JOSA A, October 1995, Vol. 12 No. 10, “Wavefront interpretation with Zernike polynomials” J. W. Wang and D. E. Silva, Applied Optics, May 1980, Vol 19, No. 9 and “Corneal wave aberration from videokeratography accuracy and limitations of the procedure”, Antonio Guirao and Pablo Artal, J Opt Soc Am A Opt Image Sci Vis June 2000, Vol 17(6):955-65.R=rpupil22(23a4-65a11)(2b)Ksq=8R3ro465a11(3b)
Figure US06609793-20030826-M00006
Calculation of Wavefront Aberration
Knowing the shape of the anterior corneal surface (Zernike coefficients described above as a's), it is possible to determine the wavefront aberration contributed by this surface using a raytrace procedure. This is described in for example “Corneal wave aberration from videokeratography: accuracy and limitations of the procedure”, Antonio Guirao and Pablo Artal, J Opt Soc Am A Opt Image Sci Vis June 2000, Vol. 17(6):955-65.
Results
Average Corneal Spherical Aberration and Shape
The 71 subjects were evaluated using the criteria described above for a 6 mm aperture. The wavefront aberration of each subject was determined after fitting the surface elevation with Zernike polynomials. FIG. 12 shows that average and standard deviation of each Zernike term (normalized format). The error bars represent ±1 standard deviation. There are three aberrations that are significantly different from zero on average in our population. Those are astigmatism (A5), coma (A9) and spherical aberration (A11). Spherical aberration is the only rotationally symmetric aberration, making it the only aberration that can be corrected with a rotationally symmetric IOL.
FIG. 13 shows a scatter plot of the value of the Zernike coefficient (OSLO format) representing spherical aberration for each of the 71 subjects before cataract surgery. The solid line in the middle represents the average spherical aberration, while the dotted lines represent +1 and −1 standard deviation. Table 8 lists the average, standard deviation, maximum and minimum values for the radius, aspheric constant, spherical aberration and root mean square error.
TABLE 8
the average, standard deviation, maximum and minimum values for the
radius, aspheric constant, spherical aberration and root mean
square error for a 6 mm aperture.
Standard
Average ValueDeviationMaximumMinimum
R (mm)7.5750.3338.7107.072
Ksq0.9270.4072.5630.0152
SA coefficient0.0006040.0004480.002003−0.000616
OSLO format (in
mm)
RMSE0.0000550.000004820.0000690.000045
Tables 9, 10 and 11 below show the corresponding results for aperture sizes of 4, 5 and 7 mm respectively. FIGS. 14,15 and16 are the corresponding scatter plots.
TABLE 9
The average, standard deviation, maximum and minimum values for the
radius, aspheric constant, spherical aberration and root mean square
error using an aperture diameter of 4 mm.
Average ValueStandard DeviationMaximumMinimum
R7.562920.3205268.6885427.067694
Ksq0.9882080.4374292.33501−0.051091
SA (A110.0001390.0001030.00041−0.000141
in mm)
RMSE4.52E−054E−060.0000540.000036
TABLE 10
The average, standard deviation, maximum and minimum values for the
radius, aspheric constant, spherical aberration and root mean square
error using an aperture diameter of 5 mm.
Average ValueStandard DeviationMaximumMinimum
R7.552630.3204478.7147047.09099
Ksq0.9456930.3640662.0454120.044609
SA (A110.000311890.0002080.000793−0.000276
in mm)
RMSE4.7E−054.02E−060.0000570.000037
TABLE 11
The average, standard deviation, maximum and minimum values for the
radius, aspheric constant, spherical aberration and root mean square
error using an aperture diameter of 7 mm.
Average ValueStandard DeviationMaximumMinimum
R7.5502260.3366328.6797127.040997
Ksq0.8983440.4168062.655164−0.04731
SA (A110.0010580.0008640.003847−0.001319
in mm)
RMSE7.58E−051.02E−050.0001120.000057
Design Cornea
One model cornea was designed and each Z11 lens power was designed using this cornea. The cornea was designed so that it had a spherical aberration that is the same as the average calculated for the population. The design cornea radii and aspheric constants are listed in Table 12 for different aperture sizes. In every case, the radius of curvature was taken to be the average radius determined from the Zernike fit data. The aspheric constant was varied until the spherical aberration value of the model cornea was equal to the average spherical aberration value for the population.
TABLE 12
The design cornea radii and aspheric constants for aperture diameters of
4, 5, 6, and 7 mm.
ApertureConic ConstantZ11
size (mm)Radius (mm)(OSLO value, K2− 1)Coefficient (mm)
47.563−0.05050.000139
57.553−0.10340.000312
67.575−0.141350.000604
77.55−0.16100.001058
As discussed previously, the 6 mm aperture diameter values are used for the design cornea. This choice enables us to design the Z11 lens so that it has no spherical aberration (when measured in a system with this cornea) over a 5.1 mm lens diameter. The OSLO surface listing for the Z11 design cornea is listed in Table 13. The refractive index of the cornea is the keratometry index of 1.3375.
These values were calculated for a model cornea having a single surface with a refractive index of the cornea of 1.3375. It is possible to use optically equivalent model formats of the cornea without departing from the scope of the invention. For example multiple surface corneas or corneas with different refractive indices could be used.
TABLE 13
OSLO surface listing for the Z11 design cornea.
ApertureConicRe-
SurfaceRadiusThicknessRadiusConstantfractive
#(mm)(mm)(mm)(cc)index
Object 1.0000e + 201.0000e + 141.0  
17.575000 3.6000003.000003−0.1413501.3375
(cornea)
22.6102331.3375
(pupil)
3 0.9000002.640231.3375
425.5194442.5502921.3375
52.2444e−051.3375
Lens Design
Each Z11 lens designed to balance the spherical aberration of the design cornea. The starting point for design was the CeeOn Edge© 911 lens described in U.S. Pat. No. 5,444,106 of the same power, with modified edge and center thickness. The lens was then placed 4.5 mm from the anterior corneal surface. The distance from the anterior corneal surface is not that critical and could be varied within reasonable limits. The surface information for the starting point eye model for the 22 D lens design process is listed in Table 14. The anterior surface of the lens was described using the formula shown inEquation 4. The variables cc, ad and ae were modified to minimize the spherical aberration. The variables are determined for an aperture size of 5.1 mm and the surface is extrapolated from these values to the optical aperture size of 6 mm. The resulting 22D Z11 eye model is listed in Table 15. The anterior surface of this 22D lens has been modified in such a way that the spherical aberration of the system (cornea+lens) is now approximately equal to 0. The wavefront aberration coefficients as calculated by OSLO for theCeeOn Edge 911 22D lens eye model and the 22D Z11 lens eye model are listed below in Table 16. Note that the coefficient representing spherical aberration for the starting point eye model is 0.001005 mm for a 6 mm diameter aperture placed at the cornea, while the same coefficient for the eye model with the designed Z11 lens is −1.3399e-06 mm. The same process as described above for a 22D lens can similarly be performed for any other lens powerz=(1R)r21+1-(1R)2(cc+1)r2+adr4+aer6(4)
Figure US06609793-20030826-M00007
TABLE 14
Surface data for the starting point averaged
eye model and a 22D lens
ApertureConicRe-
SurfaceRadiusThicknessRadiusConstantfractive
#(mm)(mm)(mm)(cc)index
Object 1.0000e+201.0000e+141.0 
1 7.575 3.6000003.000003−0.14135 1.3375
(cornea)
22.6402331.336
(pupil)
3 0.9000002.660231.336
4 (lens)11.043 1.1642.5301911.458
5 (lens)−11.043  17.15122.4209891.336
6 0.0 −0.4178470.058997
(image)
TABLE 15
Surface data for the averaged eye model and the final 22D Z11lens
ApertureConic
4thOrder6thOrder
SurfaceRadiusThicknessRadiusConstantasphoricasphericRefractive
#(mm)(mm)(mm)(cc)Constantconstantindex
Object 1.0e+201.00e+141.0 
1 7.575 3.602.000.14135 1.3375
(cornea)
22.641.336
(pupil)
3 0.902.641.336
4 (lens)11.043 1.1642.55−1.03613−0.000944−1.37e−051.458
5 (lens)17.15122.421.336
11.043
6 (image)1.59e − 05
TABLE 16
Zernike coefficients (OSLO format) for the average cornea and a
22D 911 lens and the average cornea and the 22D Z11 lens
CoefficientAverage cornea +22D 911Average cornea + 22D Z11
a1 −0.000962−1.896e−06
a2 0.00.0
a3 0.00.0
a4 2.3101e−05−3.9504e−06
a5 0.00.0
a6 0.00.0
a7 0.00.0
a8 0.00.0
a9 0.00105−1.3399e−06
a100.00.0
a110.00.0
a120.00.0
a130.00.0
a140.00.0
a150.00.0
The optical form chosen for the new Z11 design is an equiconvex lens made from a silicone with refractive index of 1.458. The spherical aberration of an average cornea is balanced by the Z11 lens yielding a system without spherical aberration. The front surface of the lens is modified such that the optical path lengths of all on-axis rays within the design aperture are the same producing a point focus. This feature can be achieved with many lens forms. The Z11 lens could therefore be designed on a convex-plano, plano-convex, non-equiconvex lens or any other design yielding a positive lens. The Z11 concept could also be extended in order to encompass a negative lens used to correct the refractive errors of the eye. The front surface or back surface could also be modified to produce the needed change in optical path difference that neutralizes the spherical aberration. There are therefore many possible designs that would achieve the goals of the Z11 lens design.

Claims (76)

What is claimed is:
1. A method of designing an intraocular lens capable of reducing aberrations of the eye after its implantation, comprising the steps of:
(i) characterizing at least one corneal surface as a mathematical model;
(ii) calculating the resulting aberrations of said corneal surface(s) by employing said mathematical model;
(iii) selecting the optical power of the intraocular lens;
(iv) modeling an intraocular lens such that a wavefront arriving from an optical system comprising said lens and corneal model obtains reduced aberrations.
2. A method according toclaim 1, comprising determining the resulting aberrations of said corneal surface(s) in a wavefront having passed said cornea.
3. A method according toclaim 1 wherein said corneal surface(s) is(are) characterized in terms of polynomials.
4. A method according toclaim 3, wherein said corneal surface(s) is(are) characterized in terms of a linear combination of polynomials.
5. A method according toclaim 3, wherein an optical system comprising said corneal model and modeled intraocular lens provides for wavefront substantially reduced from aberrations as expressed by at least one of said polynomials.
6. A method according toclaim 1, wherein said optical system further comprises complementary means for optical correction, such as spectacles or an ophthalmic correction lens.
7. A method according toclaim 1, wherein estimations of corneal refractive power and axial eye length designate the selection of lens optical power.
8. A method according toclaim 1, wherein modeling the intraocular lens includes selecting the anterior radius and surface of the lens, the posterior radius and surface of the lens, lens thickness and refractive index of the lens.
9. A method according toclaim 1 including characterizing the front corneal surface of an individual by means of topographical measurements and expressing the corneal aberrations as a combination of polynomials.
10. A method of selecting an intraocular lens that is capable of reducing aberrations of the eye after its implantation comprising the steps of:
(i) characterizing at least one corneal surface as a mathematical model;
(ii) calculating the resulting aberrations of said corneal surface(s) by employing said mathematical model;
(iii) selecting an intraocular lens having a suitable optical power from a plurality of lenses having the same power, but different aberrations;
(iv) determining if an optical system comprising said selected lens and corneal model sufficiently reduces the aberrations.
11. A method according toclaim 10, comprising determining the resulting aberrations of said corneal surface(s) in a wavefront having passed said cornea.
12. A method according toclaim 10 further comprising the steps of:
(v) calculating the aberrations of a wave front arriving from an optical system of said selected lens and corneal model;
(vi) determining if said selected intraocular lens has provided a sufficient reduction in aberrations in a wavefront arriving from said optical system; and optionally repeating steps (iii) and (iv) by selecting at least one new lens having the same optical power until finding a lens capable of sufficiently reducing the aberrations.
13. A method according toclaim 10, wherein said optical system further comprises complementary means for optical correction.
14. A method according toclaim 10, wherein said corneal surface(s) is(are) characterized in terms of a conoid of rotation.
15. A method according toclaim 10 wherein said corneal surface(s) is(are) characterized in terms of polynomials.
16. A method according toclaim 15, wherein said corneal surface(s) is(are) characterized in terms of a linear combination of polynomials.
17. A method according toclaim 15 wherein an optical system comprising said corneal model and selected intraocular lens provides for a wavefront substantially reduced from aberrations as expressed by at least one of said polynomials.
18. A method according toclaim 17, wherein said polynomials are Seidel or Zernike polynomials.
19. A method according toclaim 18, comprising the steps of:
(i) expressing the corneal aberrations as a linear combination of Zernike polynomials;
(ii) determining the corneal Zernike coefficients;
(iii) selecting the intraocular lens such that an optical system comprising said lens and cornea provides a wavefront having a sufficient reduction in Zernike coefficients.
20. A method according toclaim 19, further comprising the steps of:
(iv) calculating the Zernike coefficients resulting from an optical system comprising the modeled intraocular lens and cornea;
(v) determining if said intraocular lens has provided a reduction of Zernike coefficients; and optionally selecting a new lens until a sufficient reduction is said coefficients is obtained.
21. A method according toclaim 19, comprising determining Zernike polynomials up to the 4th order.
22. A method according toclaim 21 comprising sufficiently reducing Zernike coefficients referring to spherical aberration.
23. A method according toclaim 22 comprising sufficiently reducing Zernike coefficients above the fourth order.
24. A method according toclaim 22 comprising sufficiently reducing the 11th Zernike coefficient of a wavefront front from an optical system comprising model cornea and said selected intraocular lens, so as to obtain an eye sufficiently free from spherical aberration.
25. A method according toclaim 10, wherein corneal refractive power and axial eye length estimations designate the selection of lens optical power.
26. A method according toclaim 10 including characterizing the front corneal surface of an individual by means of topographical measurements and expressing the corneal aberrations as a combination of polynomials.
27. A method according toclaim 26 including characterizing front and rear corneal surfaces of an individual by means of topographical measurements and expressing the total corneal aberrations as a combination of polynomials.
28. A method according toclaim 26 comprising selecting a intraocular lens such that an optical system comprising said intraocular lens and cornea provides reduction of spherical aberration terms as expressed in Seidel or Zernike polynomials in a wave front having passed through the system.
29. A method according toclaim 26, wherein reduction in higher aberration terms is accomplished.
30. A method according toclaim 10, including characterizing corneal surfaces of a selected population and expressing average corneal aberrations of said population as a combination of polynomials.
31. A method according toclaim 10 characterized by selecting an intraocular lens from a kit comprising lenses with a suitable power range and within each power range a plurality of lenses having different aberrations.
32. A method according toclaim 31, wherein said aberrations are spherical aberrations.
33. A method according toclaim 31, wherein said lenses within each power range have surfaces with different aspheric components.
34. A method according toclaim 33, wherein said surfaces are the anterior surfaces.
35. A method of designing an ophthalmic lens suitable for implantation into the eye, characterized by the steps of:
selecting a representative group of patients;
collecting corneal topographic data for each subject in the group;
transferring said data to terms representing the corneal surface shape of each subject for a preset aperture size;
calculating a mean value of at least one corneal surface shape term of said group, so as to obtain at least one mean corneal surface shape term and/or calculating a mean value of at least one to the cornea corresponding corneal wavefront aberration term, each corneal wavefront aberration term being obtained by transformation through corneal surface shape terms;
from said at least one mean corneal surface shape term or from said at least one mean corneal wavefront aberration term designing an ophthalmic lens capable of reducing said at least one mean wavefront aberration term of the optical system comprising cornea and lens.
36. Method according toclaim 35, characterized in that it further comprises the steps of:
designing an average corneal model for the group of people from the calculated at least one mean corneal surface shape term or from the at least one mean corneal wavefront aberration term;
checking that the designed ophthalmic lens compensates correctly for the at least one mean aberration term by measuring these specific aberration terms of a wavefront having traveled through the model average cornea and the lens and redesigning the lens if said at least one aberration term not has been sufficiently reduced in the measured wavefront.
37. Method according toclaim 35, comprising calculating surface descriptive constant for the lens to be designed from the mean corneal surface shape terms or from the mean corneal wavefront aberration terms for a predetermined radius.
38. Method according toclaim 35, comprising selecting people in a specific age interval to constitute the group of people.
39. Method according toclaim 35, comprising selecting people who will undergo cataract surgery to constitute the group of people.
40. Method according toclaim 35, comprising designing the lens specifically for a patient that has undergone corneal surgery and therefore selecting people who have undergone corneal surgery to constitute the group of people.
41. Method according toclaim 35, comprising selecting people who have a specific ocular disease to constitute the group of people.
42. Method according toclaim 35, comprising selecting people who have a specific ocular optical defect to constitute the group of people.
43. Method according toclaim 35, further comprising the steps of:
measuring the at least one wavefront aberration term of one specific patient's cornea;
determining if the selected group corresponding to this patient is representative for this specific patient and if this is the case implant the lens designed from these average values and if this is not the case implant a lens designed from average values from another group or design an individual lens for this patient.
44. Method according toclaim 35, comprising providing the lens with at least one nonspheric surface that reduces at least one aberration term of an incoming nonspheric wavefront.
45. Method according toclaim 44, characterized in that said aberration term is a positive spherical aberration term.
46. Method according toclaim 35, comprising providing the lens with at least one nonspheric surface that reduces at least one term of a Zernike polynomial representing the aberration of an incoming nonspheric wavefront.
47. Method according toclaim 46, characterized by providing the lens with at least one nonspheric surface that reduces the 11thnormalized Zernike term representing the spherical aberration of an incoming nonspheric wavefront.
US09/863,5462000-05-232001-05-23Methods of obtaining ophthalmic lenses providing the eye with reduced aberrationsExpired - LifetimeUS6609793B2 (en)

Priority Applications (10)

Application NumberPriority DateFiling DateTitle
US09/863,546US6609793B2 (en)2000-05-232001-05-23Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US10/606,910US7241311B2 (en)2000-05-232003-06-26Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US11/619,098US20070121064A1 (en)2000-05-232007-01-02Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US11/742,996US20070258044A1 (en)2000-05-232007-05-01Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US12/175,395US7841720B2 (en)2000-05-232008-07-17Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US12/954,347US8020995B2 (en)2001-05-232010-11-24Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US13/222,944US8556426B2 (en)2000-05-262011-08-31Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US14/053,034US8998415B2 (en)2001-05-232013-10-14Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US14/668,596US9504377B2 (en)2001-05-232015-03-25Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US15/356,423US20170065165A1 (en)2001-05-232016-11-18Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations

Applications Claiming Priority (9)

Application NumberPriority DateFiling DateTitle
SE00019252000-05-23
SE0001925-72000-05-23
SE0001925ASE0001925D0 (en)2000-05-232000-05-23 Methods of obtaining ophthalmic lenses capable of reducing the aberrations of the eye
US20773400P2000-05-262000-05-26
SE00048302000-12-22
SE0004830-62000-12-22
SE0004830ASE0004830D0 (en)2000-12-222000-12-22 An ophthalmic lens and a method for designing such a lens
US25992401P2001-01-052001-01-05
US09/863,546US6609793B2 (en)2000-05-232001-05-23Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations

Related Child Applications (1)

Application NumberTitlePriority DateFiling Date
US10/606,910DivisionUS7241311B2 (en)2000-05-232003-06-26Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations

Publications (2)

Publication NumberPublication Date
US20020105617A1 US20020105617A1 (en)2002-08-08
US6609793B2true US6609793B2 (en)2003-08-26

Family

ID=27532716

Family Applications (5)

Application NumberTitlePriority DateFiling Date
US09/863,546Expired - LifetimeUS6609793B2 (en)2000-05-232001-05-23Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US10/606,910Expired - LifetimeUS7241311B2 (en)2000-05-232003-06-26Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US11/619,098AbandonedUS20070121064A1 (en)2000-05-232007-01-02Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US11/742,996AbandonedUS20070258044A1 (en)2000-05-232007-05-01Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US12/175,395Expired - Fee RelatedUS7841720B2 (en)2000-05-232008-07-17Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations

Family Applications After (4)

Application NumberTitlePriority DateFiling Date
US10/606,910Expired - LifetimeUS7241311B2 (en)2000-05-232003-06-26Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US11/619,098AbandonedUS20070121064A1 (en)2000-05-232007-01-02Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US11/742,996AbandonedUS20070258044A1 (en)2000-05-232007-05-01Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US12/175,395Expired - Fee RelatedUS7841720B2 (en)2000-05-232008-07-17Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations

Country Status (1)

CountryLink
US (5)US6609793B2 (en)

Cited By (111)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20020122153A1 (en)*2000-12-222002-09-05Piers Patricia AnnMethods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US20020196412A1 (en)*2001-05-312002-12-26Marc AbitbolAberration correction spectacle lens
US20030137635A1 (en)*2002-01-232003-07-24Menicon Co., Ltd.Contact lens and contact lens design method
US20040021826A1 (en)*2002-08-012004-02-05Sarver Edwin J.Combination advanced corneal topography/wave front aberration measurement
US20040100617A1 (en)*2000-08-012004-05-27Mordechai AbitbolApparatus for interactive optometry
US20040106992A1 (en)*2002-11-082004-06-03Lang Alan J.Multi-zonal monofocal intraocular lens for correcting optical aberrations
US20040246440A1 (en)*2001-04-272004-12-09Andino Rafael VictorAutomatic lens design and manufacturing system
US20050125055A1 (en)*2003-12-092005-06-09Jim DeaconFoldable intraocular lens and method of making
US20050125056A1 (en)*2003-12-092005-06-09Jim DeaconFoldable intraocular lens and method of making
US20050203619A1 (en)*2003-03-312005-09-15Altmann Griffith E.Aspheric lenses and lens family
US20060030938A1 (en)*2003-03-312006-02-09Altmann Griffith EAspheric lenses and lens family
US20060098162A1 (en)*2004-10-252006-05-11Bandhauer Mark HOphthalmic lens with multiple phase plates
US20070093891A1 (en)*2005-10-262007-04-26Juan TaberneroIntraocular lens for correcting corneal coma
US20070103693A1 (en)*2005-09-092007-05-10Everett Matthew JMethod of bioimage data processing for revealing more meaningful anatomic features of diseased tissues
US7237898B1 (en)*1999-10-212007-07-03Bausch & Lomb IncorporatedCustomized corneal profiling
WO2007102843A1 (en)*2006-03-082007-09-13Advanced Vision Engineering, Inc.Methods for specifying image quality of human eyes from wavefront measurements
DE102006021521A1 (en)*2006-05-052007-11-08Carl Zeiss Meditec Ag Aspherical artificial eye lens and method for the construction of such
US20070268453A1 (en)*2006-05-172007-11-22Alcon Manufacturing, Ltd.Correction of higher order aberrations in intraocular lenses
US20070279585A1 (en)*2004-11-232007-12-06Studio Bol Di Giuseppe BolliniArtificial lens, in particular a contact or intraocular lens, for correcting presbyopia, possibly associated with other visual defects, and relative production method
WO2008135624A1 (en)2007-05-072008-11-13Consejo Superior De Investigaciones CientíficasAnalytical design of intraocular lenses
US20090000628A1 (en)*2005-06-302009-01-01Visx, IncorporatedPresbyopia correction through negative high-order spherical aberration
US20090024214A1 (en)*2005-05-132009-01-22Akkolens International B.V.Intra-ocular artificial lens with variable optical strength
US20090036980A1 (en)*2000-05-232009-02-05Amo Groningen BvMethods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US20090062911A1 (en)*2007-08-272009-03-05Amo Groningen BvMultizonal lens with extended depth of focus
US20090109403A1 (en)*2007-10-312009-04-30Advanced Medical Optics, Inc.Systems and Software for Wavefront Data Processing, Vision Correction, and Other Applications
US20090157179A1 (en)*2007-12-112009-06-18Pinto Candido DOphthalmic Lenses Providing an Extended Depth of Field
US7556378B1 (en)*2003-04-102009-07-07Tsontcho IanchulevIntraoperative estimation of intraocular lens power
US20090187242A1 (en)*2007-08-272009-07-23Advanced Medical Optics, Inc.Intraocular lens having extended depth of focus
US20090210054A1 (en)*2008-02-152009-08-20Amo Regional HoldingsSystem, ophthalmic lens, and method for extending depth of focus
US20090234448A1 (en)*2007-08-272009-09-17Advanced Medical Optics, Inc.Intraocular lens having extended depth of focus
US20090268158A1 (en)*2008-04-242009-10-29Amo Regional HoldingsDiffractive Multifocal Lens Having Radially Varying Light Distribution
US20090268155A1 (en)*2008-04-242009-10-29Amo Regional HoldingsDiffractive lens exhibiting enhanced optical performance
US20100079723A1 (en)*2008-10-012010-04-01Kingston Amanda CToric Ophthalimc Lenses Having Selected Spherical Aberration Characteristics
US20100094604A1 (en)*2008-10-152010-04-15Damien GatinelMethod For Modelling An Intraocular Lens And Intraocular Lens
US20100094413A1 (en)*2006-12-132010-04-15Akkolens International B.V.Accommodating intraocular lens with variable correction
US20100097569A1 (en)*2008-10-202010-04-22Advanced Medical Optics, Inc.Multifocal Intraocular Lens
US20100100178A1 (en)*2008-10-202010-04-22Advanced Medical Optics, Inc.Multifocal Intraocular Lens
US20100100177A1 (en)*2008-10-202010-04-22Advanced Medical Optics, Inc.Multifocal Intraocular Lens
US20100281021A1 (en)*2007-12-132010-11-04Weeber Henk ACustomized multifocal ophthalmic lens
US20100318186A1 (en)*2009-05-222010-12-16Abbott Medical Optics Inc.Ophthalmic lenses with enhanced surface and methods of fabrication thereof
US20110007270A1 (en)*2009-07-062011-01-13Wavetec Vision Systems Inc.Objective quality metric for ocular wavefront measurements
US7883505B2 (en)2004-04-202011-02-08Wavetec Vision Systems, Inc.Integrated surgical microscope and wavefront sensor
US7922326B2 (en)2005-10-252011-04-12Abbott Medical Optics Inc.Ophthalmic lens with multiple phase plates
US20110102737A1 (en)*2009-08-272011-05-05Rick Edward PayorOptimizing optical aberrations in ophthalmic lenses
US20110109874A1 (en)*2009-11-062011-05-12Amo Groningen B.V.Diffractive binocular lens systems and methods
US20110149236A1 (en)*2009-12-182011-06-23Amo Groningen B.V.Single microstructure lens, systems and methods
US20110166652A1 (en)*2007-08-272011-07-07Amo Groningen B.V.Toric lens with decreased sensitivity to cylinder power and rotation and method of using the same
WO2011106610A1 (en)2010-02-252011-09-01Abbott Medical Optics Inc.Toric optic for ophthalmic use
US8020995B2 (en)2001-05-232011-09-20Amo Groningen BvMethods of obtaining ophthalmic lenses providing the eye with reduced aberrations
WO2011151497A1 (en)2010-06-022011-12-08Consejo Superior De Investigaciones Cientificas (Csic)Method for producing an isoplanatic aspheric monofocal intraocular lens, and resulting lens
WO2012082898A1 (en)2010-12-152012-06-21Abbott Medical Optics Inc.Apparatus, system, and method for intraocular lens power calculation using a regression formula incorporating corneal spherical aberration
US20120296422A1 (en)*2010-11-302012-11-22Amo Groningen BvMethod for designing, evaluating and optimizing ophthalmic lenses and laser vision correction
US8331048B1 (en)2009-12-182012-12-11Bausch & Lomb IncorporatedMethods of designing lenses having selected depths of field
WO2013055212A1 (en)2011-10-112013-04-18Akkolens International B.V.Accommodating intraocular lens with optical correction surfaces
US8545023B2 (en)2009-07-142013-10-01Wavetec Vision Systems, Inc.Ophthalmic surgery measurement system
US8550624B2 (en)2008-11-062013-10-08Wavetec Vision Systems, Inc.Optical angular measurement system for ophthalmic applications and method for positioning of a toric intraocular lens with increased accuracy
US8619405B2 (en)2007-10-312013-12-31Wavetec Vision Systems, Inc.Wavefront sensor
US8764187B2 (en)2009-07-142014-07-01Wavetec Vision Systems, Inc.Determination of the effective lens position of an intraocular lens using aphakic refractive power
US8764189B2 (en)2006-03-162014-07-01Carl Zeiss Meditec, Inc.Methods for mapping tissue with optical coherence tomography data
US8862447B2 (en)2010-04-302014-10-14Amo Groningen B.V.Apparatus, system and method for predictive modeling to design, evaluate and optimize ophthalmic lenses
US8894204B2 (en)2010-12-172014-11-25Abbott Medical Optics Inc.Ophthalmic lens, systems and methods having at least one rotationally asymmetric diffractive structure
US8974526B2 (en)2007-08-272015-03-10Amo Groningen B.V.Multizonal lens with extended depth of focus
US9072462B2 (en)2012-09-272015-07-07Wavetec Vision Systems, Inc.Geometric optical power measurement device
US9105123B2 (en)2009-08-042015-08-11Carl Zeiss Meditec, Inc.Non-linear projections of 3-D medical imaging data
US9195074B2 (en)2012-04-052015-11-24Brien Holden Vision InstituteLenses, devices and methods for ocular refractive error
US9201250B2 (en)2012-10-172015-12-01Brien Holden Vision InstituteLenses, devices, methods and systems for refractive error
US9226654B2 (en)2011-04-292016-01-05Carl Zeiss Meditec, Inc.Systems and methods for automated classification of abnormalities in optical coherence tomography images of the eye
US9335563B2 (en)2012-08-312016-05-10Amo Groningen B.V.Multi-ring lens, systems and methods for extended depth of focus
US9456894B2 (en)2008-02-212016-10-04Abbott Medical Optics Inc.Toric intraocular lens with modified power characteristics
US9541773B2 (en)2012-10-172017-01-10Brien Holden Vision InstituteLenses, devices, methods and systems for refractive error
US9561098B2 (en)2013-03-112017-02-07Abbott Medical Optics Inc.Intraocular lens that matches an image surface to a retinal shape, and method of designing same
US9579192B2 (en)2014-03-102017-02-28Amo Groningen B.V.Dual-optic intraocular lens that improves overall vision where there is a local loss of retinal function
WO2017180914A1 (en)2016-04-132017-10-19Amo Wavefront Sciences, LlcApparatus, system, and method for intraocular lens power calculation using a regression formula incorporating corneal spherical aberration
US9808340B2 (en)2011-03-242017-11-07Kowa Company, Ltd.Intraocular lens and manufacturing method thereof
WO2018037356A1 (en)2016-08-232018-03-01Medicem Ophthalmic (Cy) LimitedOphthalmic lenses with aspheric optical surfaces and method for their manufacture
US9931200B2 (en)2010-12-172018-04-03Amo Groningen B.V.Ophthalmic devices, systems, and methods for optimizing peripheral vision
US9968441B2 (en)2008-03-282018-05-15Johnson & Johnson Surgical Vision, Inc.Intraocular lens having a haptic that includes a cap
US9974646B2 (en)2012-09-052018-05-22University Of MiamiKeratoprosthesis, and system and method of corneal repair using same
US9987125B2 (en)2012-05-022018-06-05Johnson & Johnson Surgical Vision, Inc.Intraocular lens with shape changing capability to provide enhanced accomodation and visual acuity
US10010407B2 (en)2014-04-212018-07-03Amo Groningen B.V.Ophthalmic devices that improve peripheral vision
US10052194B2 (en)2009-06-262018-08-21Johnson & Johnson Surgical Vision, Inc.Accommodating intraocular lenses
US10105215B2 (en)2009-08-032018-10-23Johnson & Johnson Surgical Vision, Inc.Intraocular lens and methods for providing accommodative vision
US10206773B2 (en)2002-12-052019-02-19Johnson & Johnson Surgical Vision, Inc.Accommodating intraocular lens and method of manufacture thereof
US10456026B2 (en)2010-12-152019-10-29Amo Wavefront Sciences, LlcApparatus, system, and method for intraocular lens power calculation using a regression formula incorporating corneal spherical aberration
US10485655B2 (en)2014-09-092019-11-26Staar Surgical CompanyOphthalmic implants with extended depth of field and enhanced distance visual acuity
US10588738B2 (en)2016-03-112020-03-17Amo Groningen B.V.Intraocular lenses that improve peripheral vision
US10624735B2 (en)2016-02-092020-04-21Amo Groningen B.V.Progressive power intraocular lens, and methods of use and manufacture
US10649234B2 (en)2016-03-232020-05-12Johnson & Johnson Surgical Vision, Inc.Ophthalmic apparatus with corrective meridians having extended tolerance band
US10646329B2 (en)2016-03-232020-05-12Johnson & Johnson Surgical Vision, Inc.Ophthalmic apparatus with corrective meridians having extended tolerance band
US10653556B2 (en)2012-12-042020-05-19Amo Groningen B.V.Lenses, systems and methods for providing binocular customized treatments to correct presbyopia
US10739227B2 (en)2017-03-232020-08-11Johnson & Johnson Surgical Vision, Inc.Methods and systems for measuring image quality
US10774164B2 (en)2018-08-172020-09-15Staar Surgical CompanyPolymeric composition exhibiting nanogradient of refractive index
US10876924B2 (en)2018-02-082020-12-29Amo Groningen B.V.Wavefront based characterization of lens surfaces based on reflections
US10881504B2 (en)2016-03-092021-01-05Staar Surgical CompanyOphthalmic implants with extended depth of field and enhanced distance visual acuity
US10895517B2 (en)2018-02-082021-01-19Amo Groningen B.V.Multi-wavelength wavefront system and method for measuring diffractive lenses
US11013594B2 (en)2016-10-252021-05-25Amo Groningen B.V.Realistic eye models to design and evaluate intraocular lenses for a large field of view
US11096778B2 (en)2016-04-192021-08-24Amo Groningen B.V.Ophthalmic devices, system and methods that improve peripheral vision
US11156853B2 (en)2017-06-282021-10-26Amo Groningen B.V.Extended range and related intraocular lenses for presbyopia treatment
US11262598B2 (en)2017-06-282022-03-01Amo Groningen, B.V.Diffractive lenses and related intraocular lenses for presbyopia treatment
US11282605B2 (en)2017-11-302022-03-22Amo Groningen B.V.Intraocular lenses that improve post-surgical spectacle independent and methods of manufacturing thereof
US11327210B2 (en)2017-06-302022-05-10Amo Groningen B.V.Non-repeating echelettes and related intraocular lenses for presbyopia treatment
US11497599B2 (en)2017-03-172022-11-15Amo Groningen B.V.Diffractive intraocular lenses for extended range of vision
US11506914B2 (en)2010-12-012022-11-22Amo Groningen B.V.Multifocal lens having an optical add power progression, and a system and method of providing same
US11523897B2 (en)2017-06-232022-12-13Amo Groningen B.V.Intraocular lenses for presbyopia treatment
US11844689B2 (en)2019-12-302023-12-19Amo Groningen B.V.Achromatic lenses and lenses having diffractive profiles with irregular width for vision treatment
US11886046B2 (en)2019-12-302024-01-30Amo Groningen B.V.Multi-region refractive lenses for vision treatment
US12127934B2 (en)2014-09-092024-10-29Staar Surgical CompanyMethod of Providing Modified Monovision to a Subject with a First Lens and a Second Lens
US12204178B2 (en)2018-12-062025-01-21Amo Groningen B.V.Diffractive lenses for presbyopia treatment
US12207941B2 (en)2018-02-082025-01-28Amo Groningen B.V.Psychophysical method to characterize visual symptoms
US12239529B2 (en)2021-03-092025-03-04Amo Groningen B.V.Refractive extended depth of focus intraocular lens, and methods of use and manufacture
US12295829B2 (en)2021-10-042025-05-13Staar Surgical CompanyOphthalmic implants for correcting vision with a tunable optic, and methods of manufacture and use

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
DE19938203A1 (en)1999-08-112001-02-15Aesculap Meditec Gmbh Method and device for correcting visual defects in the human eye
US20030060878A1 (en)*2001-08-312003-03-27Shadduck John H.Intraocular lens system and method for power adjustment
US7261737B2 (en)*2002-12-122007-08-28Powervision, Inc.Accommodating intraocular lens system and method
US8048155B2 (en)2002-02-022011-11-01Powervision, Inc.Intraocular implant devices
US7209414B2 (en)*2002-11-152007-04-24Plasmon Lms, IncSpherical aberration compensation by wavelength
SE0203564D0 (en)2002-11-292002-11-29Pharmacia Groningen Bv Multifocal opthalmic lens
US7896916B2 (en)*2002-11-292011-03-01Amo Groningen B.V.Multifocal ophthalmic lens
US8361145B2 (en)*2002-12-122013-01-29Powervision, Inc.Accommodating intraocular lens system having circumferential haptic support and method
US10835373B2 (en)2002-12-122020-11-17Alcon Inc.Accommodating intraocular lenses and methods of use
US7217288B2 (en)2002-12-122007-05-15Powervision, Inc.Accommodating intraocular lens having peripherally actuated deflectable surface and method
US8328869B2 (en)2002-12-122012-12-11Powervision, Inc.Accommodating intraocular lenses and methods of use
US7036931B2 (en)*2003-01-292006-05-02Novartis AgOphthalmic lenses
GB0303193D0 (en)*2003-02-122003-03-19Guillon MichaelMethods & lens
JP2006523130A (en)2003-03-062006-10-12ジョン エイチ. シャダック, Compatible optical lens and manufacturing method
WO2004086952A2 (en)*2003-03-282004-10-14Digital Vision, LlcApplication of neuro-ocular wavefront data in vision correction
DE10325841A1 (en)*2003-06-062004-12-30Acritec Gmbh intraocular lens
DE102004009212B4 (en)*2004-02-252015-08-20Carl Zeiss Meditec Ag Contact element for laser processing and laser processing device
US7476248B2 (en)*2004-04-062009-01-13Alcon, Inc.Method of calculating the required lens power for an opthalmic implant
US9872763B2 (en)2004-10-222018-01-23Powervision, Inc.Accommodating intraocular lenses
SE0402769D0 (en)*2004-11-122004-11-12Amo Groningen Bv Method of selecting intraocular lenses
US20060116764A1 (en)*2004-12-012006-06-01Simpson Michael JApodized aspheric diffractive lenses
US20060116763A1 (en)*2004-12-012006-06-01Simpson Michael JContrast-enhancing aspheric intraocular lens
US7325927B2 (en)*2005-01-112008-02-05The University Of HoustonMethod of filtering data for the objective classification of eyes
DE602006016501D1 (en)*2005-04-052010-10-07Alcon Inc Optimal form factors for ophthalmic lenses
EP2041615A4 (en)*2005-11-092011-03-09Univ Houston METHOD FOR DESIGNING AND PRODUCING CUSTOMIZED OPTICS
US8474974B2 (en)2006-02-242013-07-02Amo Development Llc.Induced high order aberrations corresponding to geometrical transformations
US8454160B2 (en)2006-02-242013-06-04Amo Development, LlcZone extension systems and methods
US7717562B2 (en)2006-02-242010-05-18Amo Development Llc.Scaling Zernike coefficients to smaller pupil sizes for refractive treatments
US7695136B2 (en)*2007-08-012010-04-13Amo Development, Llc.Wavefront refractions and high order aberration correction when wavefront maps involve geometrical transformations
PL386800A1 (en)*2006-03-082009-05-11Scientific Optics, Inc.The manner and device for general sight improvement
AU2007227371B2 (en)*2006-03-232012-02-02Amo Manufacturing Usa, LlcSystems and methods for wavefront reconstruction for aperture with arbitrary shape
US20080004698A1 (en)*2006-06-302008-01-03Alcon, Inc.Correction of surgically-induced astigmatism during intraocular lens implants
EP2079356B1 (en)2006-07-102012-12-26AMO Manufacturing USA, LLCSystems and methods for wavefront analysis over circular and noncircular pupils
AR062067A1 (en)2006-07-172008-10-15Novartis Ag TORICAS CONTACT LENSES WITH CONTROLLED OPTICAL POWER PROFILE
FR2910645B1 (en)*2006-12-222009-07-03Essilor Int METHOD FOR DETERMINING AN OPHTHALMIC LENS
US8740381B2 (en)*2007-06-272014-06-03Bausch & Lomb IncorporatedMethod and apparatus for extrapolating diagnostic data
US8968396B2 (en)2007-07-232015-03-03Powervision, Inc.Intraocular lens delivery systems and methods of use
US8314927B2 (en)*2007-07-232012-11-20Powervision, Inc.Systems and methods for testing intraocular lenses
US8956408B2 (en)2007-07-232015-02-17Powervision, Inc.Lens delivery system
US8668734B2 (en)2010-07-092014-03-11Powervision, Inc.Intraocular lens delivery devices and methods of use
EP2671541B1 (en)2007-07-232019-04-17PowerVision, Inc.Accommodating intraocular lenses
CN101795642B (en)2007-07-232013-11-27力景公司Post-implant lens power modification
US7878651B2 (en)*2007-12-262011-02-01Carl Zeiss Meditec, Inc.Refractive prescription using optical coherence tomography
EP2265218B1 (en)*2008-04-042014-01-01AMO Regional HoldingsSystems and methods for determing intraocular lens power
KR101683042B1 (en)2008-04-042016-12-06포사이트 비젼4, 인크.Therapeutic device for pain management and vision
US8272735B2 (en)*2008-09-302012-09-25Johnson & Johnson Vision Care, Inc.Lens design simplification process
US10299913B2 (en)2009-01-092019-05-28Powervision, Inc.Accommodating intraocular lenses and methods of use
WO2010102155A1 (en)2009-03-042010-09-10Aaren Scientific Inc.System for forming and modifying lenses and lenses formed thereby
US8292952B2 (en)*2009-03-042012-10-23Aaren Scientific Inc.System for forming and modifying lenses and lenses formed thereby
US8646916B2 (en)*2009-03-042014-02-11Perfect Ip, LlcSystem for characterizing a cornea and obtaining an opthalmic lens
US8210683B2 (en)*2009-08-272012-07-03Virginia Mason Medical CenterNo-history method for intraocular lens power adjustment after excimer laser refractive surgery
EP2473138A4 (en)*2009-08-312017-08-16PowerVision, Inc.Lens capsule size estimation
ES2649890T3 (en)2009-10-232018-01-16Nexisvision, Inc. Corneal enervation for the treatment of eye pain
US9498385B2 (en)2009-10-232016-11-22Nexisvision, Inc.Conformable therapeutic shield for vision and pain
US8591025B1 (en)2012-09-112013-11-26Nexisvision, Inc.Eye covering and refractive correction methods for LASIK and other applications
US7828435B1 (en)2010-02-032010-11-09Denis RehseMethod for designing an anterior curve of a contact lens
US8900298B2 (en)2010-02-232014-12-02Powervision, Inc.Fluid for accommodating intraocular lenses
US8205987B2 (en)*2010-04-202012-06-26Carl Zeiss Vision Inc.Method for optimizing a spectacle lens for the wavefront aberrations of an eye and lens
AU2011323743B2 (en)*2010-10-252016-01-28Nexisvision, Inc.Methods and apparatus to identify eye coverings for vision
EP2688515B1 (en)2011-03-242021-05-19Alcon Inc.Intraocular lens loading systems and methods of use
BR112013024580B1 (en)*2011-04-052021-04-20Kowa Company, Ltd. method of designing intraocular lens, intraocular lens, and, group of intraocular lenses
US8678584B2 (en)2012-04-202014-03-25Nexisvision, Inc.Contact lenses for refractive correction
US12044905B2 (en)2011-04-282024-07-23Journey1 IncContact lenses for refractive correction
AU2012249773A1 (en)2011-04-282013-11-07Nexisvision, Inc.Eye covering and refractive correction methods and apparatus having improved tear flow, comfort, and/or applicability
CA2851975A1 (en)2011-10-142013-04-18Amo Groningen B.V.Apparatus, system and method to account for spherical aberration at the iris plane in the design of an intraocular lens
US10433949B2 (en)2011-11-082019-10-08Powervision, Inc.Accommodating intraocular lenses
WO2013184239A1 (en)2012-04-202013-12-12Nexisvision, Inc.Contact lenses for refractive correction
US9465233B2 (en)2012-04-202016-10-11Nexisvision, Inc.Bimodular contact lenses
FR2996161B1 (en)*2012-09-282014-10-31Essilor Int METHOD FOR MANUFACTURING AN OPHTHALMIC LENS
US20140330375A1 (en)*2013-03-112014-11-06Sean J. McCaffertyAccommodating intraocular lens system with mutually-deforming opposing surfaces
EP3785668A1 (en)2013-03-152021-03-03Alcon Inc.Intraocular lens storage and loading devices and methods of use
CN203208162U (en)*2013-04-222013-09-25爱博诺德(北京)医疗科技有限公司Aspherical intraocular lens
EP3014345A2 (en)2013-06-262016-05-04Nexisvision, Inc.Contact lenses for refractive correction
US9341864B2 (en)2013-11-152016-05-17Nexisvision, Inc.Contact lenses having a reinforcing scaffold
WO2015116559A1 (en)2014-01-292015-08-06Nexisvision, Inc.Multifocal bimodulus contact lenses
CA2941015C (en)*2014-03-072019-11-12Conexus Lens, Inc.Refocusable lens system with mutually-applanating internal surfaces
EP3307206B1 (en)2015-06-102023-09-20Alcon Inc.Intraocular lens materials and components
WO2020086603A1 (en)*2018-10-222020-04-30Dynaoptics, Inc.Lens systems using free form elements to match object space and image space, and methods therefor
WO2017079733A1 (en)2015-11-062017-05-11Powervision, Inc.Accommodating intraocular lenses and methods of manufacturing
US11000362B2 (en)2017-09-112021-05-11Amo Groningen B.V.Intraocular lenses with customized add power
US11471272B2 (en)2019-10-042022-10-18Alcon Inc.Adjustable intraocular lenses and methods of post-operatively adjusting intraocular lenses
CN114326149B (en)*2022-02-152022-09-30天津大学 A kind of spectacle lens structure and design method thereof
WO2025006182A1 (en)2023-06-302025-01-02Alcon Inc.System and methods for compensating for intraocular lens tilt
CN119828359B (en)*2025-02-192025-10-03苏州明世光学科技有限公司 Lens design method and lens capable of correcting high-order aberrations of human eyes

Citations (11)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5050981A (en)1990-07-241991-09-24Johnson & Johnson Vision Products, Inc.Lens design method and resulting aspheric lens
US5236970A (en)1987-02-051993-08-17Allergan, Inc.Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses
US5444106A (en)1992-04-211995-08-22Kabi Pharmacia Ophthalmics, Inc.High refractive index silicone compositions
US5760871A (en)*1993-01-061998-06-02Holo-Or Ltd.Diffractive multi-focal lens
US5777719A (en)1996-12-231998-07-07University Of RochesterMethod and apparatus for improving vision and the resolution of retinal images
WO1998031299A2 (en)1997-01-211998-07-23TECHNOMED GESELLSCHAFT FüR MED. UND MED.-TECHN. SYSTEME MBHMethod for producing a synthetic eye lens
US5968095A (en)1995-05-091999-10-19Pharmacia & Upjohn Groningen BvMethod of selecting an intraocular lens to be implanted into an eye
US6007747A (en)1987-08-241999-12-28Pharmacia & Upjohn CompanyMethod of making an aspheric soft lens
US6050687A (en)1999-06-112000-04-1820/10 Perfect Vision Optische Geraete GmbhMethod and apparatus for measurement of the refractive properties of the human eye
US6224211B1 (en)1999-06-082001-05-01Medjet, Inc.Super vision
US6413276B1 (en)*2000-04-262002-07-02Emmetropia, Inc.Modified intraocular lens and method of correcting optical aberrations therein

Family Cites Families (85)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
DE1805561C3 (en)1967-10-301980-10-23Societe Des Lunetiers, Paris Ophthalmic lens with strong refractive power and predetermined astigmatism
US3950082A (en)1973-01-101976-04-13David VolkOphthalmic lens for presbyopia and aphakia
US4055379A (en)1973-08-161977-10-25American Optical CorporationMultifocal lens
US3960442A (en)1974-08-051976-06-01American Optical CorporationOphthalmic lens series
US4190621A (en)1977-03-101980-02-26Martin GreshesMethod for molding optical plastic lenses of the standard and bifocal type
US4268133A (en)1978-07-141981-05-19Bausch & Lomb IncorporatedPreferential orientation of contact lenses
US4322135A (en)1978-11-291982-03-30Pilkington P. E. LimitedOptical apparatus
US4310225A (en)1979-08-061982-01-12Gentex CorporationOphthalmic lens series
US4504982A (en)*1982-08-051985-03-19Optical Radiation CorporationAspheric intraocular lens
US4522194A (en)*1983-02-181985-06-11Baylor College Of MedicineMethod and an apparatus for intra-aortic balloon monitoring and leak detection
US4580882A (en)1983-04-211986-04-08Benjamin NuchmanContinuously variable contact lens
US4512039A (en)1983-05-241985-04-23Lieberman David MMethod of offsetting postoperative astigmatism with an intraocular lens
US4640595A (en)1984-05-021987-02-03David VolkAspheric contact lens
US4710193A (en)*1986-08-181987-12-01David VolkAccommodating intraocular lens and lens series and method of lens selection
EP0308077A3 (en)1987-09-141990-05-30Nestle S.A.Synthetic intracorneal lens
US5009497A (en)1987-11-121991-04-23Cohen Allen LContact lenses utilizing keel orientation
WO1989007303A1 (en)1988-02-031989-08-10Steve NewmanImproved contact lens design
US4859261A (en)1988-05-111989-08-22Ace Ronald SMethod of making multi-focus ophthalmic lens
US5125729A (en)1991-05-031992-06-30Les Laboratoires Opti-Centre Inc.Multifocal contact lens
CA2115343A1 (en)1991-08-091993-02-18Steve NewmanToric lens with axis mislocation latitude
US5786883A (en)1991-11-121998-07-28Pilkington Barnes Hind, Inc.Annular mask contact lenses
TW210380B (en)1992-04-231993-08-01Ciba Geigy Ag
US5282852A (en)1992-09-021994-02-01Alcon Surgical, Inc.Method of calculating the required power of an intraocular lens
US5771088A (en)1993-03-271998-06-23Pilkington Barnes Hind, Inc.Contact lens designed to accommodate and correct for the effects of presbyopia
DE4403326C1 (en)1994-02-031995-06-22Hans Reinhard Prof Dr Koch Intraocular lens arrangement for astigmatism correction
US20030060880A1 (en)1994-04-082003-03-27Vladimir FeingoldToric intraocular lens
US5507806A (en)1994-05-131996-04-16Pharmacia Iovision, Inc.Multi-faceted intraocular lens
EP0785759B1 (en)1994-10-062004-03-31FEINGOLD, VladimirIntraocular contact lens
US5766016A (en)*1994-11-141998-06-16Georgia Tech Research CorporationSurgical simulator and method for simulating surgical procedure
IL117937A0 (en)1995-05-041996-08-04Johnson & Johnson Vision ProdCombined multifocal toric lens designs
US5652638A (en)1995-05-041997-07-29Johnson & Johnson Vision Products, Inc.Concentric annular ring lens designs for astigmatism
IL118064A0 (en)1995-05-041996-08-04Johnson & Johnson Vision ProdConcentric annular ring lens designs for astigmatic presbyopes
IL118065A0 (en)1995-05-041996-08-04Johnson & Johnson Vision ProdAspheric toric lens designs
WO1996039106A1 (en)1995-06-061996-12-12Scientific Optics, Inc.Asymmetric bifocal intraocular lens
US6280470B1 (en)1995-10-202001-08-28Gholam A. PeymanIntrastromal corneal modification
US5715090A (en)*1996-02-201998-02-03Eastman Kodak CompanyColor corrected viewfinder including a negative power lens component having a diffractive surface
US5880809A (en)1996-12-301999-03-09Scientific Optics, Inc.Contact lens
PT900403E (en)1996-03-212003-10-31Sola Int Holdings PERFORATED MONOVAY LENSES
US5817130A (en)*1996-05-031998-10-06Sulzer Intermedics Inc.Implantable cardiac cardioverter/defibrillator with EMI suppression filter with independent ground connection
EP0864112B1 (en)1996-07-052003-04-02Rodenstock GmbHProgressive spectacle lenses
JPH1078566A (en)1996-09-051998-03-24Asahi Optical Co Ltd Eyeglass lens
JPH10175148A (en)1996-10-141998-06-30Nikon Corp Substrate for plastic lens, apparatus and method for manufacturing the same
US5754270A (en)1996-11-081998-05-19Unilens Corp., UsaMultifocal lens utilizing rapid power shift transition zone
ID20540A (en)1997-04-071999-01-07Bausch & Lomb METHOD FOR UNTUYK IDENTIFY THE CHARACTERISTICS OF THE CONTACT LENS
US5963299A (en)1997-07-221999-10-05Reyburn; Thomas P.Method and apparatus for measuring toric contact lens rotation
US6089710A (en)1998-07-202000-07-18Oracle Lens Manufacturing CorporationSingle-vision ophthalmic lens series
FR2769997B1 (en)1997-10-161999-12-31Essilor Int MULTIFOCAL OPHTHALMIC LENS
US6260966B1 (en)1998-03-112001-07-17Menicon Co. Ltd.Multifocal ocular lens
US6203156B1 (en)1998-03-312001-03-20Johnson & Johnson Vision Care, Inc.Contact lenses bearing marks
JP4023902B2 (en)1998-04-102007-12-19株式会社メニコン Toric multifocal lens
US6416550B2 (en)1998-04-152002-07-09Alcon Manufacturing, Ltd.Method of selecting an intraocular lens material
US6491721B2 (en)1998-04-152002-12-10Alcon Manufacturing, Ltd.Toric intraocular lens material
EP1103014A4 (en)1998-08-062006-09-06John B W LettMultifocal aspheric lens
FR2783938B1 (en)1998-09-282000-11-17Essilor Int TORIC OPHTHALMIC LENSES
US7303281B2 (en)1998-10-072007-12-04Tracey Technologies, LlcMethod and device for determining refractive components and visual function of the eye for vision correction
US6082856A (en)1998-11-092000-07-04Polyvue Technologies, Inc.Methods for designing and making contact lenses having aberration control and contact lenses made thereby
US6176578B1 (en)1998-12-092001-01-23Johnson & Johnson Vision Care, Inc.Toric contact lenses
US6197058B1 (en)1999-03-222001-03-06Valdemar PortneyCorrective intraocular lens system and intraocular lenses and lens handling device therefor
US6616692B1 (en)*1999-04-302003-09-09Advanced Medical Optics, Inc.Intraocular lens combinations
US20060238702A1 (en)*1999-04-302006-10-26Advanced Medical Optics, Inc.Ophthalmic lens combinations
US6176579B1 (en)1999-07-072001-01-23Softfocal Co., IncBifocal contact lens with toric transition
US6305802B1 (en)*1999-08-112001-10-23Johnson & Johnson Vision Products, Inc.System and method of integrating corneal topographic data and ocular wavefront data with primary ametropia measurements to create a soft contact lens design
US6106118A (en)1999-09-052000-08-22Johnson & Johnson Vision Products, Inc.Progressive addition lenses
US6086204A (en)1999-09-202000-07-11Magnante; Peter C.Methods and devices to design and fabricate surfaces on contact lenses and on corneal tissue that correct the eye's optical aberrations
US6428573B2 (en)2000-02-032002-08-06Howard J. BarnettIntraocular multifocal lens construction
DE10006896A1 (en)*2000-02-162001-08-30Wavelight Laser Technologie AgProduction of an intraocular or optical contact lens a blank is produced mechanically and the surface profile material is removed by laser beams according to the calculated structure required to correct the vision
US6390623B1 (en)2000-03-292002-05-21Johnson & Johnson Vision Care, Inc.Customized progressive addition lenses
US6419359B2 (en)*2000-04-112002-07-16James Alan EdwardsSurface design method
US6413277B1 (en)2000-05-182002-07-02Tobias H. NeuhannMethod for intraocular lens insertion and apparatus
US6609793B2 (en)2000-05-232003-08-26Pharmacia Groningen BvMethods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US6655803B1 (en)2000-06-012003-12-02Inray Ltd.Wavefront method for designing optical elements
US6454409B1 (en)2000-08-152002-09-24Johnson & Johnson Vision Care, Inc.Contact lenses
US6582076B1 (en)2000-08-302003-06-24Johnson & Johnson Vision Care, Inc.Ophthalmic lenses useful in correcting astigmatism and presbyopia
US6595639B1 (en)2000-11-102003-07-22Ocular Sciences, Inc.Junctionless ophthalmic lenses and methods for making same
SE0004829D0 (en)2000-12-222000-12-22Pharmacia Groningen Bv Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
AU2002240147A1 (en)2001-02-012002-08-12Tekia, Inc.Two part "l"- or "s"-shaped phakic iol
US6455409B1 (en)*2001-02-282002-09-24Advanced Micro Devices, Inc.Damascene processing using a silicon carbide hard mask
US6709105B2 (en)2001-04-102004-03-23Johnson & Johnson Vision Care, Inc.Progressive addition lenses
US6638305B2 (en)2001-05-152003-10-28Advanced Medical Optics, Inc.Monofocal intraocular lens convertible to multifocal intraocular lens
JP2002350785A (en)2001-05-282002-12-04Menicon Co Ltd How to design ophthalmic lenses
US20030014107A1 (en)2001-06-282003-01-16Michael ReynardMultifocal phakic intraocular lens
US6533416B1 (en)2001-07-202003-03-18Ocular Sciences, Inc.Contact or intraocular lens and method for its preparation
US20030033011A1 (en)2001-08-082003-02-13Singer Jack A.Intraocular lens for vision correction and cataract prevention
US6663240B2 (en)2002-05-152003-12-16Alcon, Inc.Method of manufacturing customized intraocular lenses
DE602006016501D1 (en)*2005-04-052010-10-07Alcon Inc Optimal form factors for ophthalmic lenses

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5236970A (en)1987-02-051993-08-17Allergan, Inc.Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses
US6007747A (en)1987-08-241999-12-28Pharmacia & Upjohn CompanyMethod of making an aspheric soft lens
US5050981A (en)1990-07-241991-09-24Johnson & Johnson Vision Products, Inc.Lens design method and resulting aspheric lens
US5444106A (en)1992-04-211995-08-22Kabi Pharmacia Ophthalmics, Inc.High refractive index silicone compositions
US5760871A (en)*1993-01-061998-06-02Holo-Or Ltd.Diffractive multi-focal lens
US5968095A (en)1995-05-091999-10-19Pharmacia & Upjohn Groningen BvMethod of selecting an intraocular lens to be implanted into an eye
US5777719A (en)1996-12-231998-07-07University Of RochesterMethod and apparatus for improving vision and the resolution of retinal images
US6095651A (en)*1996-12-232000-08-01University Of RochesterMethod and apparatus for improving vision and the resolution of retinal images
WO1998031299A2 (en)1997-01-211998-07-23TECHNOMED GESELLSCHAFT FüR MED. UND MED.-TECHN. SYSTEME MBHMethod for producing a synthetic eye lens
US6224211B1 (en)1999-06-082001-05-01Medjet, Inc.Super vision
US6050687A (en)1999-06-112000-04-1820/10 Perfect Vision Optische Geraete GmbhMethod and apparatus for measurement of the refractive properties of the human eye
US6413276B1 (en)*2000-04-262002-07-02Emmetropia, Inc.Modified intraocular lens and method of correcting optical aberrations therein

Non-Patent Citations (15)

* Cited by examiner, † Cited by third party
Title
Artal, Pablo, et al. Nov. 1, 1998/vol. 23, No. 21/Optic Letters; 1713-1715.
Atchison, David A. Ophthal. Physiol. Opt., 1991, vol. 11, Apr.; 137-146.
Database PubMed "Online!" NCBI; Seitz et al "Corneal Topography," Database Accession No. 10170448 XP002177903 (1997).
Glasser, Adrian, et al.,Vision Res., vol. 38, No. 2, pp. 209-229, 1998.
Greivenkamp, John E., et al. vol. 120, No. 2 American Journal of Ophthalmology 1995; 227-240.
Guirao, Antonia, et al. vol. 17, No. 6/Jun. 2000/J. Opt. Soc. Am. A; 955-965.
IOVS, Mar. 15, 1999, vol. 40, No. 4; S535.
IOVS, Mar. 15, 1999, vol. 40, No. 4; S545.
Liang, Junzhong, et al. vol. 11, No. 7/Jul. 1994'J. opt. Soc. Am. A; 1949-1957.
Malacara, Daniel, et. al. Optical Engineering/ Jun. 1990/vol. 29 No. 6; 672-675.
Oshika, Tetsuro, et al. Investigative Ophthalmology & Visual Science, Jun. 1999, vol. 40, No. 7; 1351-1355.
Patel, S., et al., Refractive & Corneal Surgery vol. 9, May/Jun. 1993; 172-181.
Schwiegerlind, Jim, et al. vol. 12, No. 10/Oct. 1995/J. Opt. Soc. Am. A; 2105-2113.
Smith, George, et al., G. Smith et al./Vision Research 41 (2001); 235-243.
Wang, J.Y., et al. Applied Optics/vol. 19, No. 9/May 1, 1980; 1510-1518.

Cited By (288)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US7237898B1 (en)*1999-10-212007-07-03Bausch & Lomb IncorporatedCustomized corneal profiling
US7841720B2 (en)2000-05-232010-11-30Amo Groningen B.V.Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US20090036980A1 (en)*2000-05-232009-02-05Amo Groningen BvMethods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US8556426B2 (en)2000-05-262013-10-15Amo Groningen B.V.Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US20040100617A1 (en)*2000-08-012004-05-27Mordechai AbitbolApparatus for interactive optometry
US20020122153A1 (en)*2000-12-222002-09-05Piers Patricia AnnMethods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US6705729B2 (en)*2000-12-222004-03-16Pharmacia Groningen BvMethods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US7137702B2 (en)2000-12-222006-11-21Amo Groningen B.V.Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US20040183996A1 (en)*2000-12-222004-09-23Patricia Ann PiersMethods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US20060274261A1 (en)*2001-04-272006-12-07Andino Rafael VAutomatic lens design and manufacturing system
US7762667B2 (en)2001-04-272010-07-27Novartis AgAutomatic lens design and manufacturing system
US7775663B2 (en)2001-04-272010-08-17Novartis AgAutomatic lens design and manufacturing system
US7780293B2 (en)2001-04-272010-08-24Novartis AgAutomatic lens design and manufacturing system
US20040246440A1 (en)*2001-04-272004-12-09Andino Rafael VictorAutomatic lens design and manufacturing system
US7111938B2 (en)2001-04-272006-09-26Novartis AgAutomatic lens design and manufacturing system
US20060274262A1 (en)*2001-04-272006-12-07Andino Rafael VAutomatic lens design and manufacturing system
US8998415B2 (en)2001-05-232015-04-07Amo Groningen B.V.Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US8020995B2 (en)2001-05-232011-09-20Amo Groningen BvMethods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US9504377B2 (en)2001-05-232016-11-29Amo Groningen B.V.Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US20020196412A1 (en)*2001-05-312002-12-26Marc AbitbolAberration correction spectacle lens
US6786602B2 (en)*2001-05-312004-09-07Marc AbitbolAberration correction spectacle lens
US20030137635A1 (en)*2002-01-232003-07-24Menicon Co., Ltd.Contact lens and contact lens design method
US7029117B2 (en)*2002-01-232006-04-18Menicon Co., Ltd.Contact lens and contact lens design method
US20040021826A1 (en)*2002-08-012004-02-05Sarver Edwin J.Combination advanced corneal topography/wave front aberration measurement
US7381221B2 (en)2002-11-082008-06-03Advanced Medical Optics, Inc.Multi-zonal monofocal intraocular lens for correcting optical aberrations
US20040106992A1 (en)*2002-11-082004-06-03Lang Alan J.Multi-zonal monofocal intraocular lens for correcting optical aberrations
US10206773B2 (en)2002-12-052019-02-19Johnson & Johnson Surgical Vision, Inc.Accommodating intraocular lens and method of manufacture thereof
US7905917B2 (en)2003-03-312011-03-15Bausch & Lomb IncorporatedAspheric lenses and lens family
US20050203619A1 (en)*2003-03-312005-09-15Altmann Griffith E.Aspheric lenses and lens family
US20110098810A1 (en)*2003-03-312011-04-28Altmann Griffith EAspheric Lenses and Lens Family
US20060030938A1 (en)*2003-03-312006-02-09Altmann Griffith EAspheric lenses and lens family
US8535376B2 (en)*2003-03-312013-09-17Bausch & Lomb IncorporatedAspheric lenses and lens family
US20100030225A1 (en)*2003-04-102010-02-04Tsontcho IanchulevIntraoperative Estimation of Intraocular Lens Power
US8632185B2 (en)2003-04-102014-01-21Wavetec Vision Systems, Inc.Intraoperative estimation of intraocular lens power
US9445890B2 (en)2003-04-102016-09-20Wavetec Vision Systems, Inc.Intraoperative estimation of intraocular lens power
US9168127B2 (en)2003-04-102015-10-27Wavetec Vision Systems, Inc.Intraoperative estimation of intraocular lens power
US7988291B2 (en)2003-04-102011-08-02Wavetec Vision Systems, Inc.Intraoperative estimation of intraocular lens power
US20100036386A1 (en)*2003-04-102010-02-11Tsontcho IanchulevIntraoperative Estimation of Intraocular Lens Power
US7556378B1 (en)*2003-04-102009-07-07Tsontcho IanchulevIntraoperative estimation of intraocular lens power
US8313196B2 (en)2003-04-102012-11-20Wavetec Vision Systems, Inc.Intraoperative estimation of intraocular lens power
EP2255752A2 (en)2003-11-102010-12-01Abbott Medical Optics Inc.Multi-zonal monofocal intraocular lens for correcting optical aberrations
US8382832B2 (en)2003-12-092013-02-26Abbott Medical Optics Inc.Foldable intraocular lens and method of making
US20100036490A1 (en)*2003-12-092010-02-11Abbott Medical Optics Inc.Foldable intraocular lens and method of making
US10028822B2 (en)2003-12-092018-07-24Johnson & Johnson Surgical Vision, Inc.Foldable intraocular lens and method of making
US9737396B2 (en)2003-12-092017-08-22Abbott Medical Optics Inc.Foldable intraocular lens and method of making
US20050125055A1 (en)*2003-12-092005-06-09Jim DeaconFoldable intraocular lens and method of making
US7615073B2 (en)2003-12-092009-11-10Advanced Medical Optics, Inc.Foldable intraocular lens and method of making
US7621949B2 (en)2003-12-092009-11-24Advanced Medical Optics, Inc.Foldable intraocular lens and method of making
US10420639B2 (en)2003-12-092019-09-24Johnson & Johnson Surgical Vision, Inc.Foldable intraocular lens and method of making
US20050125056A1 (en)*2003-12-092005-06-09Jim DeaconFoldable intraocular lens and method of making
US9259308B2 (en)2003-12-092016-02-16Abbott Medical Optics Inc.Foldable intraocular lens and method of making
US8394083B2 (en)2004-04-202013-03-12Wavetec Vision Systems, Inc.Integrated surgical microscope and wavefront sensor
US9420949B2 (en)2004-04-202016-08-23Wavetec Vision Systems, Inc.Integrated surgical microscope and wavefront sensor
US9107612B2 (en)2004-04-202015-08-18Wavetec Vision Systems, Inc.Integrated surgical microscope and wavefront sensor
US7883505B2 (en)2004-04-202011-02-08Wavetec Vision Systems, Inc.Integrated surgical microscope and wavefront sensor
US8475439B2 (en)2004-04-202013-07-02Wavetec Vision Systems, Inc.Integrated surgical microscope and wavefront sensor
US8157374B2 (en)2004-10-252012-04-17Abbott Medical Optics Inc.Ophthalmic lens with multiple phase plates
US20060098162A1 (en)*2004-10-252006-05-11Bandhauer Mark HOphthalmic lens with multiple phase plates
US8506075B2 (en)2004-10-252013-08-13Abbott Medical Optics Inc.Ophthalmic lens with multiple phase plates
US7455404B2 (en)2004-10-252008-11-25Advanced Medical Optics, Inc.Ophthalmic lens with multiple phase plates
US7984990B2 (en)2004-10-252011-07-26Abbot Medical Optics Inc.Ophthalmic lens with multiple phase plates
US20070279585A1 (en)*2004-11-232007-12-06Studio Bol Di Giuseppe BolliniArtificial lens, in particular a contact or intraocular lens, for correcting presbyopia, possibly associated with other visual defects, and relative production method
US8603167B2 (en)2005-05-132013-12-10Akkolens International B.V.Intra-ocular artificial lens with variable optical strength
US20090024214A1 (en)*2005-05-132009-01-22Akkolens International B.V.Intra-ocular artificial lens with variable optical strength
US8142499B2 (en)2005-06-302012-03-27Amo Manufacturing Usa, Llc.Presbyopia correction through negative high-order spherical aberration
US20090216218A1 (en)*2005-06-302009-08-27Amo Manufacturing Usa, LlcPresbyopia correction through negative spherical aberration
US20090000628A1 (en)*2005-06-302009-01-01Visx, IncorporatedPresbyopia correction through negative high-order spherical aberration
US9358154B2 (en)*2005-06-302016-06-07Amo Manufacturing Usa, LlcPresbyopia correction through negative spherical aberration
US10213102B2 (en)2005-06-302019-02-26Amo Manufacturing Usa, LlcPresbyopia correction through negative spherical aberration
US8416991B2 (en)2005-09-092013-04-09Carl Zeiss Meditec, Inc.Method of bioimage data processing for revealing more meaningful anatomic features of diseased tissues
US8913793B2 (en)2005-09-092014-12-16Carl Zeiss Meditec, Inc.Method of bioimage data processing for revealing more meaningful anatomic features of diseased tissues
US20070103693A1 (en)*2005-09-092007-05-10Everett Matthew JMethod of bioimage data processing for revealing more meaningful anatomic features of diseased tissues
US8208688B2 (en)2005-09-092012-06-26Carl Zeiss Meditec, Inc.Method of bioimage data processing for revealing more meaningful anatomic features of diseased tissues
US20100226542A1 (en)*2005-09-092010-09-09Carl Zeiss Meditec, Inc.Method of bioimage data processing for revealing more meaningful anatomic features of diseased tissues
US7668342B2 (en)*2005-09-092010-02-23Carl Zeiss Meditec, Inc.Method of bioimage data processing for revealing more meaningful anatomic features of diseased tissues
US8073202B2 (en)*2005-09-092011-12-06Carl Zeiss Meditec, Inc.Method of bioimage data processing for revealing more meaningful anatomic features of diseased tissues
US7922326B2 (en)2005-10-252011-04-12Abbott Medical Optics Inc.Ophthalmic lens with multiple phase plates
US8801781B2 (en)2005-10-262014-08-12Abbott Medical Optics Inc.Intraocular lens for correcting corneal coma
US20070093891A1 (en)*2005-10-262007-04-26Juan TaberneroIntraocular lens for correcting corneal coma
WO2007102843A1 (en)*2006-03-082007-09-13Advanced Vision Engineering, Inc.Methods for specifying image quality of human eyes from wavefront measurements
US8764189B2 (en)2006-03-162014-07-01Carl Zeiss Meditec, Inc.Methods for mapping tissue with optical coherence tomography data
WO2007128423A1 (en)*2006-05-052007-11-15Carl Zeiss Meditec AgAspheric intraocular lens and method for designing such iol
US20090125105A1 (en)*2006-05-052009-05-14Cedric LesageAspheric intraocular lens and method for making the same
CN101437468B (en)*2006-05-052012-07-18卡尔蔡司医疗技术股份公司Aspheric intraocular lens and method for designing such iol
US20110157548A1 (en)*2006-05-052011-06-30Lesage CedricMethod for making an aspheric intraocular lens
US8235525B2 (en)*2006-05-052012-08-07Carl Zeiss Meditec AgMethod for making an aspheric intraocular lens
AU2007247491B2 (en)*2006-05-052010-12-16Carl Zeiss Meditec AgAspheric intraocular lens and method for designing such IOL
DE102006021521A1 (en)*2006-05-052007-11-08Carl Zeiss Meditec Ag Aspherical artificial eye lens and method for the construction of such
US20070268453A1 (en)*2006-05-172007-11-22Alcon Manufacturing, Ltd.Correction of higher order aberrations in intraocular lenses
US8211172B2 (en)2006-05-172012-07-03Novartis AgCorrection of higher order aberrations in intraocular lenses
US20110085133A1 (en)*2006-05-172011-04-14Xin HongCorrection of higher order aberrations in intraocular lenses
US8852273B2 (en)2006-05-172014-10-07Novartis AgCorrection of higher order aberrations in intraocular lenses
US7879089B2 (en)2006-05-172011-02-01Alcon, Inc.Correction of higher order aberrations in intraocular lenses
US10463473B2 (en)2006-12-132019-11-05Akkolens International B.V.Accommodating intraocular lens with variable correction
US20100094413A1 (en)*2006-12-132010-04-15Akkolens International B.V.Accommodating intraocular lens with variable correction
WO2008135624A1 (en)2007-05-072008-11-13Consejo Superior De Investigaciones CientíficasAnalytical design of intraocular lenses
US20100271591A1 (en)*2007-05-072010-10-28Consejo Superior De Investigaciones CientíficasAnalytical design of intraocular lenses
US8974526B2 (en)2007-08-272015-03-10Amo Groningen B.V.Multizonal lens with extended depth of focus
US20110166652A1 (en)*2007-08-272011-07-07Amo Groningen B.V.Toric lens with decreased sensitivity to cylinder power and rotation and method of using the same
AU2008293695B2 (en)*2007-08-272014-02-06Johnson & Johnson Surgical Vision, Inc.Multizonal aspheric lens with extended depth of focus
EP2182891B1 (en)*2007-08-272014-04-09Abbott Medical Optics Inc.Multizonal aspheric lens with extended depth of focus
US20090234448A1 (en)*2007-08-272009-09-17Advanced Medical Optics, Inc.Intraocular lens having extended depth of focus
US8740978B2 (en)2007-08-272014-06-03Amo Regional HoldingsIntraocular lens having extended depth of focus
US9216080B2 (en)2007-08-272015-12-22Amo Groningen B.V.Toric lens with decreased sensitivity to cylinder power and rotation and method of using the same
US9987127B2 (en)2007-08-272018-06-05Amo Groningen B.V.Toric lens with decreased sensitivity to cylinder power and rotation and method of using the same
US20090187242A1 (en)*2007-08-272009-07-23Advanced Medical Optics, Inc.Intraocular lens having extended depth of focus
WO2009029515A1 (en)2007-08-272009-03-05Advanced Medical Optics, Inc.Multizonal aspheric lens with extended depth of focus
US8747466B2 (en)2007-08-272014-06-10Amo Groningen, B.V.Intraocular lens having extended depth of focus
US11452595B2 (en)2007-08-272022-09-27Amo Groningen B.V.Multizonal lens with enhanced performance
US10265162B2 (en)2007-08-272019-04-23Amo Groningen B.V.Multizonal lens with enhanced performance
US20090062911A1 (en)*2007-08-272009-03-05Amo Groningen BvMultizonal lens with extended depth of focus
US20100103378A1 (en)*2007-10-312010-04-29Abbott Medical Optics Inc.Systems and software for wavefront data processing, vision correction, and other applications
US9295381B2 (en)2007-10-312016-03-29Wavetec Vision Systems, Inc.Wavefront sensor
US8162480B2 (en)2007-10-312012-04-24Abbott Medical Optics Inc.Systems and software for wavefront data processing, vision correction, and other applications
US7654672B2 (en)2007-10-312010-02-02Abbott Medical Optics Inc.Systems and software for wavefront data processing, vision correction, and other applications
US20090109403A1 (en)*2007-10-312009-04-30Advanced Medical Optics, Inc.Systems and Software for Wavefront Data Processing, Vision Correction, and Other Applications
US8619405B2 (en)2007-10-312013-12-31Wavetec Vision Systems, Inc.Wavefront sensor
US20090157179A1 (en)*2007-12-112009-06-18Pinto Candido DOphthalmic Lenses Providing an Extended Depth of Field
US9724190B2 (en)2007-12-132017-08-08Amo Groningen B.V.Customized multifocal ophthalmic lens
US20100281021A1 (en)*2007-12-132010-11-04Weeber Henk ACustomized multifocal ophthalmic lens
US9454018B2 (en)2008-02-152016-09-27Amo Groningen B.V.System, ophthalmic lens, and method for extending depth of focus
US10034745B2 (en)2008-02-152018-07-31Amo Groningen B.V.System, ophthalmic lens, and method for extending depth of focus
US20090210054A1 (en)*2008-02-152009-08-20Amo Regional HoldingsSystem, ophthalmic lens, and method for extending depth of focus
US9456894B2 (en)2008-02-212016-10-04Abbott Medical Optics Inc.Toric intraocular lens with modified power characteristics
US9968441B2 (en)2008-03-282018-05-15Johnson & Johnson Surgical Vision, Inc.Intraocular lens having a haptic that includes a cap
US7871162B2 (en)2008-04-242011-01-18Amo Groningen B.V.Diffractive multifocal lens having radially varying light distribution
US8231219B2 (en)2008-04-242012-07-31Amo Groningen B.V.Diffractive lens exhibiting enhanced optical performance
US20090268158A1 (en)*2008-04-242009-10-29Amo Regional HoldingsDiffractive Multifocal Lens Having Radially Varying Light Distribution
US8573775B2 (en)2008-04-242013-11-05Amo Groningen B.V.Diffractive lens exhibiting enhanced optical performance
US8382281B2 (en)2008-04-242013-02-26Amo Groningen B.V.Diffractive multifocal lens having radially varying light distribution
US20090268155A1 (en)*2008-04-242009-10-29Amo Regional HoldingsDiffractive lens exhibiting enhanced optical performance
US20110109875A1 (en)*2008-04-242011-05-12Amo Groningen B.V.Diffractive multifocal lens having radially varying light distribution
US10180585B2 (en)2008-05-132019-01-15Amo Groningen B.V.Single microstructure lens, systems and methods
US10197815B2 (en)2008-05-132019-02-05Amo Groningen B.V.Multi-ring lens, systems and methods for extended depth of focus
US9557580B2 (en)2008-05-132017-01-31Amo Groningen B.V.Limited echelette lens, systems and methods
US10288901B2 (en)2008-05-132019-05-14Amo Groningen B.V.Limited echellette lens, systems and methods
US9581834B2 (en)2008-05-132017-02-28Amo Groningen B.V.Single microstructure lens, systems and methods
US20100079723A1 (en)*2008-10-012010-04-01Kingston Amanda CToric Ophthalimc Lenses Having Selected Spherical Aberration Characteristics
US20100094604A1 (en)*2008-10-152010-04-15Damien GatinelMethod For Modelling An Intraocular Lens And Intraocular Lens
EP2177179A1 (en)2008-10-152010-04-21Carl Zeiss Meditec France S.A.S.Method for modelling an intraocular lens and intraocular lens
US20100097569A1 (en)*2008-10-202010-04-22Advanced Medical Optics, Inc.Multifocal Intraocular Lens
US8292953B2 (en)2008-10-202012-10-23Amo Groningen B.V.Multifocal intraocular lens
US20100100177A1 (en)*2008-10-202010-04-22Advanced Medical Optics, Inc.Multifocal Intraocular Lens
US8771348B2 (en)2008-10-202014-07-08Abbott Medical Optics Inc.Multifocal intraocular lens
US8734511B2 (en)2008-10-202014-05-27Amo Groningen, B.V.Multifocal intraocular lens
US20100100178A1 (en)*2008-10-202010-04-22Advanced Medical Optics, Inc.Multifocal Intraocular Lens
US9622856B2 (en)2008-10-202017-04-18Abbott Medical Optics Inc.Multifocal intraocular lens
US10327887B2 (en)2008-10-202019-06-25Johnson & Johnson Surgical Vision, Inc.Multifocal intraocular lens
US9307904B2 (en)2008-11-062016-04-12Wavetec Vision Systems, Inc.Optical angular measurement system for ophthalmic applications and method for positioning of a toric intraocular lens with increased accuracy
US8550624B2 (en)2008-11-062013-10-08Wavetec Vision Systems, Inc.Optical angular measurement system for ophthalmic applications and method for positioning of a toric intraocular lens with increased accuracy
US9554892B2 (en)2009-05-222017-01-31Abbott Medical Optics Inc.Ophthalmic lenses with enhanced surface and methods of fabrication thereof
US10390938B2 (en)2009-05-222019-08-27Johnson & Johnson Surgical Vision, Inc.Ophthalmic lenses with enhanced surface and methods of fabrication thereof
US20100318186A1 (en)*2009-05-222010-12-16Abbott Medical Optics Inc.Ophthalmic lenses with enhanced surface and methods of fabrication thereof
US10052194B2 (en)2009-06-262018-08-21Johnson & Johnson Surgical Vision, Inc.Accommodating intraocular lenses
US20110007270A1 (en)*2009-07-062011-01-13Wavetec Vision Systems Inc.Objective quality metric for ocular wavefront measurements
US9603516B2 (en)2009-07-062017-03-28Wavetec Vision Systems, Inc.Objective quality metric for ocular wavefront measurements
US8876290B2 (en)2009-07-062014-11-04Wavetec Vision Systems, Inc.Objective quality metric for ocular wavefront measurements
US8545023B2 (en)2009-07-142013-10-01Wavetec Vision Systems, Inc.Ophthalmic surgery measurement system
US8764187B2 (en)2009-07-142014-07-01Wavetec Vision Systems, Inc.Determination of the effective lens position of an intraocular lens using aphakic refractive power
US9554697B2 (en)2009-07-142017-01-31Wavetec Vision Systems, Inc.Determination of the effective lens position of an intraocular lens using aphakic refractive power
US9259149B2 (en)2009-07-142016-02-16Wavetec Vision Systems, Inc.Ophthalmic surgery measurement system
US10105215B2 (en)2009-08-032018-10-23Johnson & Johnson Surgical Vision, Inc.Intraocular lens and methods for providing accommodative vision
US9105123B2 (en)2009-08-042015-08-11Carl Zeiss Meditec, Inc.Non-linear projections of 3-D medical imaging data
US8342683B2 (en)2009-08-272013-01-01Novartis AgOptimizing optical aberrations in ophthalmic lenses
US20110102737A1 (en)*2009-08-272011-05-05Rick Edward PayorOptimizing optical aberrations in ophthalmic lenses
US20110109874A1 (en)*2009-11-062011-05-12Amo Groningen B.V.Diffractive binocular lens systems and methods
US8623083B2 (en)2009-11-062014-01-07Amo Groningen B.V.Diffractive binocular lens systems and methods
US9122074B2 (en)2009-11-062015-09-01Amo Groningen B.V.Diffractive binocular lens systems and methods
US20110149236A1 (en)*2009-12-182011-06-23Amo Groningen B.V.Single microstructure lens, systems and methods
US8430508B2 (en)2009-12-182013-04-30Amo Groningen B.V.Single microstructure lens, systems and methods
US8331048B1 (en)2009-12-182012-12-11Bausch & Lomb IncorporatedMethods of designing lenses having selected depths of field
US8926092B2 (en)2009-12-182015-01-06Amo Groningen B.V.Single microstructure lens, systems and methods
US8444267B2 (en)2009-12-182013-05-21Amo Groningen B.V.Ophthalmic lens, systems and methods with angular varying phase delay
US8480228B2 (en)2009-12-182013-07-09Amo Groningen B.V.Limited echelette lens, systems and methods
US8820927B2 (en)2009-12-182014-09-02Amo Groningen, B.V.Limited echelette lens, systems and methods
US8256896B2 (en)2010-02-252012-09-04Abbott Medical Optic Inc.Toric optic for ophthalmic use
WO2011106610A1 (en)2010-02-252011-09-01Abbott Medical Optics Inc.Toric optic for ophthalmic use
US8521318B2 (en)2010-02-252013-08-27Abbott Medical Optics Inc.Toric optic for ophthalmic use
US8862447B2 (en)2010-04-302014-10-14Amo Groningen B.V.Apparatus, system and method for predictive modeling to design, evaluate and optimize ophthalmic lenses
WO2011151497A1 (en)2010-06-022011-12-08Consejo Superior De Investigaciones Cientificas (Csic)Method for producing an isoplanatic aspheric monofocal intraocular lens, and resulting lens
US10448819B2 (en)2010-11-302019-10-22Amo Groningen B.V.Method for designing, evaluating and optimizing ophthalmic lenses and laser vision correction
US20120296422A1 (en)*2010-11-302012-11-22Amo Groningen BvMethod for designing, evaluating and optimizing ophthalmic lenses and laser vision correction
US11506914B2 (en)2010-12-012022-11-22Amo Groningen B.V.Multifocal lens having an optical add power progression, and a system and method of providing same
US8623081B2 (en)2010-12-152014-01-07Amo Groningen B.V.Apparatus, system, and method for intraocular lens power calculation using a regression formula incorporating corneal spherical aberration
WO2012082898A1 (en)2010-12-152012-06-21Abbott Medical Optics Inc.Apparatus, system, and method for intraocular lens power calculation using a regression formula incorporating corneal spherical aberration
US10456026B2 (en)2010-12-152019-10-29Amo Wavefront Sciences, LlcApparatus, system, and method for intraocular lens power calculation using a regression formula incorporating corneal spherical aberration
US9393108B2 (en)2010-12-152016-07-19Amo Groningen B.V.Apparatus, system, and method for intraocular lens power calculation using a regression formula incorporating corneal spherical aberration
US10136805B2 (en)2010-12-152018-11-27Amo Groningen B.V.Apparatus, system, and method for intraocular lens power calculation using a regression formula incorporating corneal spherical aberration
US9931200B2 (en)2010-12-172018-04-03Amo Groningen B.V.Ophthalmic devices, systems, and methods for optimizing peripheral vision
US8894204B2 (en)2010-12-172014-11-25Abbott Medical Optics Inc.Ophthalmic lens, systems and methods having at least one rotationally asymmetric diffractive structure
US9808340B2 (en)2011-03-242017-11-07Kowa Company, Ltd.Intraocular lens and manufacturing method thereof
US11020219B2 (en)2011-03-242021-06-01Kowa Company, Ltd.Intraocular lens and manufacturing method thereof
US10076242B2 (en)2011-04-292018-09-18Doheny Eye InstituteSystems and methods for automated classification of abnormalities in optical coherence tomography images of the eye
US9226654B2 (en)2011-04-292016-01-05Carl Zeiss Meditec, Inc.Systems and methods for automated classification of abnormalities in optical coherence tomography images of the eye
WO2013055212A1 (en)2011-10-112013-04-18Akkolens International B.V.Accommodating intraocular lens with optical correction surfaces
US10203522B2 (en)2012-04-052019-02-12Brien Holden Vision InstituteLenses, devices, methods and systems for refractive error
US10209535B2 (en)2012-04-052019-02-19Brien Holden Vision InstituteLenses, devices and methods for ocular refractive error
US11809024B2 (en)2012-04-052023-11-07Brien Holden Vision Institute LimitedLenses, devices, methods and systems for refractive error
US10838235B2 (en)2012-04-052020-11-17Brien Holden Vision Institute LimitedLenses, devices, and methods for ocular refractive error
US12298605B2 (en)2012-04-052025-05-13Brien Holden Vision Institute LimitedLenses, devices, methods and systems for refractive error
US11644688B2 (en)2012-04-052023-05-09Brien Holden Vision Institute LimitedLenses, devices and methods for ocular refractive error
US10948743B2 (en)2012-04-052021-03-16Brien Holden Vision Institute LimitedLenses, devices, methods and systems for refractive error
US9535263B2 (en)2012-04-052017-01-03Brien Holden Vision InstituteLenses, devices, methods and systems for refractive error
US9195074B2 (en)2012-04-052015-11-24Brien Holden Vision InstituteLenses, devices and methods for ocular refractive error
US9575334B2 (en)2012-04-052017-02-21Brien Holden Vision InstituteLenses, devices and methods of ocular refractive error
US10466507B2 (en)2012-04-052019-11-05Brien Holden Vision Institute LimitedLenses, devices and methods for ocular refractive error
US9987125B2 (en)2012-05-022018-06-05Johnson & Johnson Surgical Vision, Inc.Intraocular lens with shape changing capability to provide enhanced accomodation and visual acuity
US12158638B2 (en)2012-08-312024-12-03Amo Groningen B.V.Multi-ring lens, systems and methods for extended depth of focus
US11022815B2 (en)2012-08-312021-06-01Amo Groningen B.V.Multi-ring lens, systems and methods for extended depth of focus
US9335563B2 (en)2012-08-312016-05-10Amo Groningen B.V.Multi-ring lens, systems and methods for extended depth of focus
US9974646B2 (en)2012-09-052018-05-22University Of MiamiKeratoprosthesis, and system and method of corneal repair using same
US9339180B2 (en)2012-09-272016-05-17Wavetec Vision Systems, Inc.Geometric optical power measurement device
US9072462B2 (en)2012-09-272015-07-07Wavetec Vision Systems, Inc.Geometric optical power measurement device
US11320672B2 (en)2012-10-072022-05-03Brien Holden Vision Institute LimitedLenses, devices, systems and methods for refractive error
US11333903B2 (en)2012-10-172022-05-17Brien Holden Vision Institute LimitedLenses, devices, methods and systems for refractive error
US12360398B2 (en)2012-10-172025-07-15Brien Holden Vision Institute LimitedLenses, devices, systems and methods for refractive error
US12298604B2 (en)2012-10-172025-05-13Brien Holden Vision Institute LimitedLenses, devices, methods and systems for refractive error
US9541773B2 (en)2012-10-172017-01-10Brien Holden Vision InstituteLenses, devices, methods and systems for refractive error
US10520754B2 (en)2012-10-172019-12-31Brien Holden Vision Institute LimitedLenses, devices, systems and methods for refractive error
US10534198B2 (en)2012-10-172020-01-14Brien Holden Vision Institute LimitedLenses, devices, methods and systems for refractive error
US9201250B2 (en)2012-10-172015-12-01Brien Holden Vision InstituteLenses, devices, methods and systems for refractive error
US9759930B2 (en)2012-10-172017-09-12Brien Holden Vision InstituteLenses, devices, systems and methods for refractive error
US11389329B2 (en)2012-12-042022-07-19Amo Groningen B.V.Lenses, systems and methods for providing binocular customized treatments to correct presbyopia
US10653556B2 (en)2012-12-042020-05-19Amo Groningen B.V.Lenses, systems and methods for providing binocular customized treatments to correct presbyopia
US9561098B2 (en)2013-03-112017-02-07Abbott Medical Optics Inc.Intraocular lens that matches an image surface to a retinal shape, and method of designing same
US10758340B2 (en)2013-03-112020-09-01Johnson & Johnson Surgical Vision, Inc.Intraocular lens that matches an image surface to a retinal shape, and method of designing same
US11331181B2 (en)2014-03-102022-05-17Amo Groningen B.V.Fresnel piggyback intraocular lens that improves overall vision where there is a local loss of retinal function
US10136990B2 (en)2014-03-102018-11-27Amo Groningen B.V.Piggyback intraocular lens that improves overall vision where there is a local loss of retinal function
US9867693B2 (en)2014-03-102018-01-16Amo Groningen B.V.Intraocular lens that improves overall vision where there is a local loss of retinal function
US10456242B2 (en)2014-03-102019-10-29Amo Groningen B.V.Intraocular lens that improves overall vision where there is a local loss of retinal function
US9579192B2 (en)2014-03-102017-02-28Amo Groningen B.V.Dual-optic intraocular lens that improves overall vision where there is a local loss of retinal function
US11534291B2 (en)2014-03-102022-12-27Amo Groningen B.V.Intraocular lens that improves overall vision where there is a local loss of retinal function
US9636215B2 (en)2014-03-102017-05-02Amo Groningen B.V.Enhanced toric lens that improves overall vision where there is a local loss of retinal function
US11517423B2 (en)2014-03-102022-12-06Amo Groningen B.V.Piggyback intraocular lens that improves overall vision where there is a local loss of retinal function
US10016270B2 (en)2014-03-102018-07-10Amo Groningen B.V.Dual-optic intraocular lens that improves overall vision where there is a local loss of retinal function
US10327888B2 (en)2014-03-102019-06-25Amo Groningen B.V.Enhanced toric lens that improves overall vision where there is a local loss of retinal function
US10143548B2 (en)2014-03-102018-12-04Amo Groningen B.V.Fresnel piggyback intraocular lens that improves overall vision where there is a local loss of retinal function
US10010407B2 (en)2014-04-212018-07-03Amo Groningen B.V.Ophthalmic devices that improve peripheral vision
US10588739B2 (en)2014-04-212020-03-17Amo Groningen B.V.Ophthalmic devices, system and methods that improve peripheral vision
US11660183B2 (en)2014-04-212023-05-30Amo Groningen B.V.Ophthalmic devices, system and methods that improve peripheral vision
US12232952B2 (en)2014-09-092025-02-25Staar Surgical CompanyOphthalmic implants with extended depth of field and enhanced distance visual acuity
US12127934B2 (en)2014-09-092024-10-29Staar Surgical CompanyMethod of Providing Modified Monovision to a Subject with a First Lens and a Second Lens
US10485655B2 (en)2014-09-092019-11-26Staar Surgical CompanyOphthalmic implants with extended depth of field and enhanced distance visual acuity
US10624735B2 (en)2016-02-092020-04-21Amo Groningen B.V.Progressive power intraocular lens, and methods of use and manufacture
US10709550B2 (en)2016-02-092020-07-14Amo Groningen B.V.Progressive power intraocular lens, and methods of use and manufacture
US12213876B2 (en)2016-02-092025-02-04Amo Groningen B.V.Progressive power intraocular lens, and methods of use and manufacture
US12121433B2 (en)2016-02-092024-10-22Amo Groningen B.V.Progressive power intraocular lens, and methods of use and manufacture
US11116624B2 (en)2016-02-092021-09-14Amo Groningen B.V.Progressive power intraocular lens, and methods of use and manufacture
US12257144B2 (en)2016-02-092025-03-25Amo Groningen B.V.Progressive power intraocular lens, and methods of use and manufacture
US10881504B2 (en)2016-03-092021-01-05Staar Surgical CompanyOphthalmic implants with extended depth of field and enhanced distance visual acuity
US10588738B2 (en)2016-03-112020-03-17Amo Groningen B.V.Intraocular lenses that improve peripheral vision
US11160651B2 (en)2016-03-112021-11-02Amo Groningen B.V.Intraocular lenses that improve peripheral vision
US11793626B2 (en)2016-03-112023-10-24Amo Groningen B.V.Intraocular lenses that improve peripheral vision
US10670885B2 (en)2016-03-232020-06-02Johnson & Johnson Surgical Vision, Inc.Ophthalmic apparatus with corrective meridians having extended tolerance band with freeform refractive surfaces
US10646329B2 (en)2016-03-232020-05-12Johnson & Johnson Surgical Vision, Inc.Ophthalmic apparatus with corrective meridians having extended tolerance band
US10712589B2 (en)2016-03-232020-07-14Johnson & Johnson Surgical Vision, Inc.Ophthalmic apparatus with corrective meridians having extended tolerance band by modifying refractive powers in uniform meridian distribution
US11123178B2 (en)2016-03-232021-09-21Johnson & Johnson Surgical Vision, Inc.Power calculator for an ophthalmic apparatus with corrective meridians having extended tolerance or operation band
US11291538B2 (en)2016-03-232022-04-05Johnson & Johnson Surgical Vision, Inc.Ophthalmic apparatus with corrective meridians having extended tolerance band
US11281025B2 (en)2016-03-232022-03-22Johnson & Johnson Surgical Vision, Inc.Ophthalmic apparatus with corrective meridians having extended tolerance band by modifying refractive powers in uniform meridian distribution
US11249326B2 (en)2016-03-232022-02-15Johnson & Johnson Surgical Vision, Inc.Ophthalmic apparatus with corrective meridians having extended tolerance band
US11231600B2 (en)2016-03-232022-01-25Johnson & Johnson Surgical Vision, Inc.Ophthalmic apparatus with corrective meridians having extended tolerance band with freeform refractive surfaces
US10649234B2 (en)2016-03-232020-05-12Johnson & Johnson Surgical Vision, Inc.Ophthalmic apparatus with corrective meridians having extended tolerance band
WO2017180914A1 (en)2016-04-132017-10-19Amo Wavefront Sciences, LlcApparatus, system, and method for intraocular lens power calculation using a regression formula incorporating corneal spherical aberration
US11877924B2 (en)2016-04-192024-01-23Amo Groningen B.V.Ophthalmic devices, system and methods that improve peripheral vision
US11096778B2 (en)2016-04-192021-08-24Amo Groningen B.V.Ophthalmic devices, system and methods that improve peripheral vision
WO2018037356A1 (en)2016-08-232018-03-01Medicem Ophthalmic (Cy) LimitedOphthalmic lenses with aspheric optical surfaces and method for their manufacture
US11013594B2 (en)2016-10-252021-05-25Amo Groningen B.V.Realistic eye models to design and evaluate intraocular lenses for a large field of view
US11497599B2 (en)2017-03-172022-11-15Amo Groningen B.V.Diffractive intraocular lenses for extended range of vision
US11385126B2 (en)2017-03-232022-07-12Johnson & Johnson Surgical Vision, Inc.Methods and systems for measuring image quality
US10739227B2 (en)2017-03-232020-08-11Johnson & Johnson Surgical Vision, Inc.Methods and systems for measuring image quality
US11523897B2 (en)2017-06-232022-12-13Amo Groningen B.V.Intraocular lenses for presbyopia treatment
US11156853B2 (en)2017-06-282021-10-26Amo Groningen B.V.Extended range and related intraocular lenses for presbyopia treatment
US11262598B2 (en)2017-06-282022-03-01Amo Groningen, B.V.Diffractive lenses and related intraocular lenses for presbyopia treatment
US11914229B2 (en)2017-06-282024-02-27Amo Groningen B.V.Diffractive lenses and related intraocular lenses for presbyopia treatment
US11573433B2 (en)2017-06-282023-02-07Amo Groningen B.V.Extended range and related intraocular lenses for presbyopia treatment
US11327210B2 (en)2017-06-302022-05-10Amo Groningen B.V.Non-repeating echelettes and related intraocular lenses for presbyopia treatment
US11282605B2 (en)2017-11-302022-03-22Amo Groningen B.V.Intraocular lenses that improve post-surgical spectacle independent and methods of manufacturing thereof
US11881310B2 (en)2017-11-302024-01-23Amo Groningen B.V.Intraocular lenses that improve post-surgical spectacle independent and methods of manufacturing thereof
US12207941B2 (en)2018-02-082025-01-28Amo Groningen B.V.Psychophysical method to characterize visual symptoms
US10895517B2 (en)2018-02-082021-01-19Amo Groningen B.V.Multi-wavelength wavefront system and method for measuring diffractive lenses
US10876924B2 (en)2018-02-082020-12-29Amo Groningen B.V.Wavefront based characterization of lens surfaces based on reflections
US11427665B2 (en)2018-08-172022-08-30Staar Surgical CompanyPolymeric composition exhibiting nanogradient of refractive index
US10774164B2 (en)2018-08-172020-09-15Staar Surgical CompanyPolymeric composition exhibiting nanogradient of refractive index
US12204178B2 (en)2018-12-062025-01-21Amo Groningen B.V.Diffractive lenses for presbyopia treatment
US11886046B2 (en)2019-12-302024-01-30Amo Groningen B.V.Multi-region refractive lenses for vision treatment
US11844689B2 (en)2019-12-302023-12-19Amo Groningen B.V.Achromatic lenses and lenses having diffractive profiles with irregular width for vision treatment
US12239529B2 (en)2021-03-092025-03-04Amo Groningen B.V.Refractive extended depth of focus intraocular lens, and methods of use and manufacture
US12295829B2 (en)2021-10-042025-05-13Staar Surgical CompanyOphthalmic implants for correcting vision with a tunable optic, and methods of manufacture and use

Also Published As

Publication numberPublication date
US20070121064A1 (en)2007-05-31
US7241311B2 (en)2007-07-10
US7841720B2 (en)2010-11-30
US20090036980A1 (en)2009-02-05
US20020105617A1 (en)2002-08-08
US20070258044A1 (en)2007-11-08
US20040088050A1 (en)2004-05-06

Similar Documents

PublicationPublication DateTitle
US6609793B2 (en)Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
EP2332495B1 (en)Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US6705729B2 (en)Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US9504377B2 (en)Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
AU2001263942A1 (en)Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US20040156014A1 (en)Multifocal ophthalmic lens
AU2002234579A1 (en)Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
ZA200209763B (en)Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations.

Legal Events

DateCodeTitleDescription
ASAssignment

Owner name:PHARMACIA AB, SWEDEN

Free format text:ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NORRBY, SVERKER;ARTAL, PABLO;PIERS, PATRICIA ANN;AND OTHERS;REEL/FRAME:012568/0280;SIGNING DATES FROM 20010917 TO 20010918

ASAssignment

Owner name:PHARMACIA GRONINGEN BV, NETHERLANDS

Free format text:ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PHARMACIA AB;REEL/FRAME:014164/0860

Effective date:20030416

STCFInformation on status: patent grant

Free format text:PATENTED CASE

CCCertificate of correction
ASAssignment

Owner name:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, CA

Free format text:SECURITY AGREEMENT;ASSIGNOR:ADVANCED MEDICAL OPTICS, INC.;REEL/FRAME:014913/0655

Effective date:20040625

ASAssignment

Owner name:AMO GRONINGEN B.V., NETHERLANDS ANTILLES

Free format text:CHANGE OF NAME;ASSIGNOR:PHARMACIA GRONINGEN B.V.;REEL/FRAME:016536/0455

Effective date:20040626

FPAYFee payment

Year of fee payment:4

ASAssignment

Owner name:ADVANCED MEDICAL OPTICS, INC., CALIFORNIA

Free format text:RELEASE OF SECURITY INTEREST AT REEL/FRAME NO. 14913/0655;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:019111/0753

Effective date:20070402

FPAYFee payment

Year of fee payment:8

FPAYFee payment

Year of fee payment:12


[8]ページ先頭

©2009-2025 Movatter.jp